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Abstract 
 
The involvement of Si in cardiovascular diseases has been 
suggested by several authors. However, only a small number of 
studies have investigated the Si content of human aortic tissue. 
The aim of this study was to investigate age- and gender-related 
changes in silicon levels of the human aorta. Moreover, 
associations were sought between silicon and structural 
components, e.g. elastin of the aortic wall, as to enlighten 
possible associations between silicon and aortic health.  
Forty thoracic aortas, obtained post-mortem from female and 
male subjects between 45 and 83 years old, were analysed for 
Si content and other elements (Al, B, Cu, Fe, Mn, Zn, Ca, K, Mg, 
Na and P) by ICP-OES. Elastin was quantified using a 
colorimetric dye-binding method Fastin™ Elastin assay. 
Silicon levels in the aorta samples did not vary significantly 
with age or gender. Relevant correlations with the Si 
concentration in the aorta were observed for (1) Cu in the 
female samples with a significant positive correlation, and (2) a 
negative correlation with P levels, although this was not 
significant. Analysis of the elastin concentration in the aorta 
samples revealed no gender- or age-related changes, although 
a trend for a decrease in older subjects (< 66 years) was 
observed. Elastin levels did not correlate with the Si 
concentrations in the aorta samples, but a negative correlation 
was observed with Cu in samples from female donors and with 
K (male and female). Additionally, Si levels in the aorta were 
also similar to levels analysed in skin biopsy samples (male and 
female: n = 47, age range = 19 – 72), where a trend for 
increasing Si levels with ageing was observed in female 
subjects. 
Results from the present study could be used to support the 
suggestion that silicon affects factors that are involved in 
progression of aortic stiffness, including the utilization of copper, 
essential in preventing oxidative damage to adult elastin fibres, 
and decreasing the adsorption of phosphorus to the matrix 
proteins and thereby prevent the calcification of the aortic wall. 
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Resumo 
 
O envolvimento do silício em doenças cardiovasculares, 
particularmente aterosclerose, foi sugerido por vários autores. 
No entanto, apenas um número reduzido de estudos 
investigaram a concentração de Si em aortas humanas. Este 
estudo teve como objectivo investigar alterações no conteúdo de 
Si e elastina com a idade e sexo em amostras de aortas 
humanas. Foram também investigadas correlações entre as 
concentrações de silício e elastina. 
Silício e outros elementos (Al, B, Cu, Fe, Mn, Zn, Ca, K, Mg, 
Na e P) foram quantificados, através de ICP-OES, em 40 aortas 
torácicas, obtidas post-mortem de indivíduos de sexo masculino 
e feminino com idades compreendidas entre os 54 e 83 anos. O 
conteúdo de elastina destas amostras foi determinado através 
do método colorimétrico Fastin™ Elastin assay. 
Não foram observadas correlações significativas entre a 
concentração de Si nas amostras de aorta com a idade ou sexo 
dos indivíduos. Correlações entre a concentração de Si e outros 
elementos foram também investigadas e, para além de uma 
correlação positiva e significativa, observada entre Si e Cu em 
amostras provenientes de indivíduos do sexo feminino, foi 
também identificada uma correlação negativa entre Si e P, 
embora não significantiva. A quantificação de elastina nas 
amostras de aorta não demonstrou alterações significantivas 
com a idade ou sexo dos pacientes, no entanto foi observado 
um decréscimo na concentração de elastina em individuos de 
idade avançada (< 66 anos). Correlações negativas relevantes 
foram observadas entre a elastina e K, e entre elastina e Cu em 
amostras de indivíduos do sexo feminino. Não foram 
identificadas correlações significativas entre a concentração de 
elastina e Si nas amostras de aorta analisadas. Adicionalmente, 
a concentração de Si na aorta humana foi semelhante à 
quantidade determinada em amostras de biópsias da pele 
humana (indivíduos do sexo feminino e masculino: n = 47, faixa 
etária = 19 – 72), onde foi observada uma tendência para o 
aumento da concentração de Si com o envelhecimento em 
indivíduos do sexo feminino. 
Os resultados deste estudo poderão ser usados para apoiar a 
hipótese de que o Si interage com factores que estão envolvidos 
no envelhecimento vascular e progressivo aumento da rigidez 
da aorta. Estes incluém a utilização de cobre, essencial na 
prevenção de danos oxidativos em fibras elásticas maduras 
(elastina), e também a diminuição da absorção de fósforo em 
proteínas da matriz extracelular, consequentemente, impedindo 
a calcificação da parede da aorta. 
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1 MRC – Human Nutrition Research 
1.1 BioMineral Research Group 
 Since the 20th century, scientists have identified different food nutrients and 
defined nutritional standards and recommendations in order to prevent 
deficiencies and promote human health. The BioMineral Research (BMR) group 
concentrates on the role of minerals in health and disease, and focuses 
particularly in nano-mineral synthesis to help provide new solutions for more 
bioavailable mineral supplements. 
Silicon is not yet generally accepted as an essential nutrient for humans, although 
numerous studies suggest an important role in bone formation, blood vessels and 
brain health1. In 1972 Carlisle and, Schwarz & Milne first reported that silicon 
deficiency in chicks and rats, respectively, led to severe bone and connective 
tissue defects (cartilage and joints) and that these abnormalities could be 
corrected by silicon supplementation2. In the same decade other reports appeared 
suggesting that, in addition to the aging process, inadequate dietary silicon 
intake may contribute to some cases of atherosclerosis and hypertension3, 4; 
hypothesizing a preventive role for silicon in cardiovascular health.  
 Total dietary silicon intake varies greatly between cultures and feeding 
habits, as it is related to the amounts and proportions of food consumed from 
animal (low silicon) and plant (high silicon) origin, and the amounts of refined 
and processed foods in the diet5. Bioavailable dietary silicon supplements can be 
used to optimize dietary silicon intake and consequently improved quality of life. 
 Focusing on human clinical data, this project proposed to evaluate the 
possible link between cardiovascular health and nutrition, particularly the silicon 
content of the ageing aortas and ultimately to provide clues of the biological role 
of silicon in cardiovascular health and inform upon dietary silicon requirements 
for a healthy aorta. 
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1.2 Aims and scopes 
 The distribution of silicon in animal tissues, the nature of the Si interactions 
with connective tissues and their components has led to the supposition of an 
essential if not, an important role for Si in the maintenance of the architecture and 
resilience of the aortic wall. Not considering the positive results published by 
Loeper in 1979, on the effect of silicon in cardiovascular diseases, namely 
atherosclerosis, only a small number of studies have investigated the effect of Si 
on aortic health. The data currently available is not enough to reach any firm 
conclusions. Results vary greatly and most were obtained before the 
development of suitable and accurate methods for trace element 
analysis/quantification. 
 The BMR group hypothesized that the Si concentration of the human aorta 
decreases with ageing and that this reduction correlates with the decrease in 
elastin content and the decrease in mechanical performance, e.g. elasticity, of the 
ageing aorta. The aim of this project was to investigate age- and gender-related 
changes in silicon levels of human aortas, obtained from male and female organ 
donors of different ages. Moreover, associations were sought between silicon 
content and elastin concentrations of the aorta. The content of other physiological 
important elements in the human aorta were also investigated to determine the 
specificity of the associations with silicon. 
 A secondary objective was the development of a biochemical assay that 
would allow the accurate measurement of the total collagen and elastin contents 
in human aortas using a single sample for both assays. 
  
 The research project was divided into two parts: I. Mineral and biochemical 
study of human aortas: via multi-element quantification by ICP-OES and elastin 
measurement by colorimetric assays; and II. Method development for elastin and 
collagen quantification using a single specimen for both analyses.  
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2 Introduction 
2.1 Silicon 
 Silicon (Si) is ubiquitous element in our environment found mainly as solid 
phase silicates in rocks (quartz) and soil minerals. The process of weathering 
gradually releases soluble silicates, mainly orthosilicic acid (or silicic acid), 
Si(OH)4, a highly bioavailable Si source, into natural water bodies (Figure 1). For 
years, Si was considered a non-essential trace element, a “fortuitous reminder of 
our geochemical origins”. Only now this element is being recognized as an 
important trace element for the normal growth and development and, general 
health of higher animals6. 
 
Figure 1 - Silicon and silica chemistry. Silicic acid: soluble molecule with high bioavailability, at 
concentrations above 2mM Si, Si(OH)4 starts to polymerise towards insoluble polymer/colloidal species. 
Crystalline and amorphous silica: forms of silicon dioxide or silicates with low bioavailability, most 
commonly found as quartz and soil minerals. Adapted from Martin, 2007 7. 
 Dietary intake and food sources 2.1.1
 Total dietary silicon intake varies greatly between cultures and feeding 
habits, as it is related to the amounts and proportions of food consumed from 
animal (low silicon) and plant (high silicon) origin and the amounts of refined 
and processed foods in the diet. Dietary intake of Si is between 20-50 mg Si/day 
< 
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for most Western populations8 (Figure 2). The highest levels (and sources) of Si 
are found amongst plant-based foods, especially whole grains, oats, barley, rice 
and wheat. Likewise, products made from grains are also high in Si, such as 
breakfast cereals, bread, pasta, biscuits and beer8, 9. Although tap water has a 
relatively low Si content, it has the potential to be a major source to overall Si 
intake due to the amount normally consumed directly or as an ingredient and/or 
diluent, e.g. in the preparation of foods and beverages. Manufacturing processes 
may also affect the Si content of foods. For example dry fruits have relatively 
high Si levels, since the drying process further increases their Si content due to 
water loss9. 
 
Figure 2 - Major (top 10) food sources that contribute to the total silicon intake in the male population of 
the Framingham cohort study (USA). Adapted from Jugdaohsingh, 2002 8. 
  Silicon absorption and excretion 2.1.2
 The mechanism of absorption and excretion of Si is still poorly understood. 
Nonetheless, it is known that the orthosilicic acid in foods and beverages is 
readily and rapidly absorbed in the proximal small intestine. Other forms 
(species) of silica need to be broken down to Si(OH)4 prior to absorption in the 
gastrointestinal tract10. The silicon is absorbed across the intestinal mucosa 
reaches the blood circulation, where it is found virtually non-protein bound11, 
and then is readily excreted by the kidneys10. Renal function appears to have an 
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important role in the maintenance of the baseline serum Si concentrations after 
food ingestion (Figure 3). Moreover it was verified that with any impairment in 
renal function (e.g. uraemic patients), urinary elimination of silicon decreases and 
serum silicon concentration increases12. 
 
Figure 3 - Silicon uptake and excretion. Uptake of Si into serum, following ingestion (at t=0 h) of an 
orthosilicic acid solution (of 55.2 mg/L Si) in a healthy fasted volunteer. Ingestion of orthosilicic acid 
markedly increased serum Si levels and peak concentration was observed between 60 and 84 min. Silicon 
was rapidly cleared from serum and levels quickly returned to baseline level. Adapted from Reffitt, 199910. 
  Tissue distribution and metabolism 2.1.3
 Data on silicon concentrations in living tissues is very limited and varies 
greatly and are generally higher in earlier reports (pre 1980’s). Moreover, most of 
the studies were perform in animals (Figure 4) and, although a similar tissue 
distribution of Si is expected in humans, this has not been investigated12. The 
development of new and more accurate analytical methods, such as atomic 
emission spectroscopy techniques, as well as the increasing awareness for 
environmental sample contaminations, are the most plausible explanations for 
the more recent lower levels reported13. 
 Normal fasting serum Si levels in adults are between 70 – 150 μg/L and 
increase up to 800 μg/L with ingestion of foods-containing silicon8. 
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Figure 4 - Normal tissue silicon levels in the rat, expressed in mg/kg (ppm) of wet weight of tissue. 
Carlisle, 197814. 
 In the rat the highest silicon levels are found in aorta and other connective 
tissues such as bone, tendon, trachea and skin14 (Figure 4). Amongst human 
tissues besides the connective tissues previously mentioned, e.g. aorta, tendon 
and bone, higher levels of Si were localized in skin and, hair, and lower levels 
were reported in soft tissues such as liver, heart, adrenals and brain3. The reasons 
behind the high silicon content in connective tissues are suggested to be linked 
with the association of this element with the glycosaminoglycan and 
polyuronides fractions, contributing to the structural framework and resilience of 
connective tissues15. 
 Several investigators have postulated that sex and endocrine hormones may 
regulate the tissue distribution of Si in tissues and its utilization at the cellular 
level16, 17. In a cross-sectional population based study, dietary Si intake was found 
to be positively and significantly correlated with bone mineral density at the hip 
site in men and pre-menopausal women; but not in post-menopausal women18 
(Figure 5). A subsequent women only study confirmed the association in pre-
menopausal women and showed a restoration of Si bone mineral correlation in 
post-menopausal women who were taking or had previously taken hormone 
replacement therapy19. The difference in the magnitude of the silicon effect 
between post-menopausal women and men and pre-menopausal women led to 
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the conclusion that hormonal factors may be involved. In post-menopausal 
women circulating estrogen levels are markedly reduced compared to pre-
menopausal women, while in men levels are slightly higher than post-
menopausal women and little change occurs in estrogen metabolism with 
ageing18. 
 
Figure 5 - Correlations between dietary silicon intake and adjusted bone mineral density at the total hip 
in pre-menopausal, post-menopausal women and mean. Jugdaohsingh, 200418. 
2.2 Silicon and aortic health 
 Silicon is not yet generally accepted as an essential nutrient for humans, 
although numerous studies suggest an important role in bone formation, blood 
vessels and brain health12. 
 In 1972 Carlisle and, Schwarz & Milne first reported that silicon deficiency 
in chicks and rats, respectively, led to severe bone and connective tissue defects 
(cartilage and joints) and that these abnormalities could be corrected by silicon 
supplementation14 (Figure 6). In the same decade, Loeper and colleagues reported 
that the silicon content of normal human aorta decreases markedly with ageing 
and that the concentration of silicon in the arterial wall decreases with the 
development of atherosclerosis. Furthermore, they stated that “Si partially 
inhibits lipid deposition by maintaining the normal calibre of elastic fibres, with 
occasional thickening and proliferation of these fibres”3 (Figure 7). 
13 
 
 
Figure 6 - Carlisle Si deprivation study in chicks. Four week old chicks maintained on a silicon-replete 
(left) and silicon-deficient (right) diet. Chicks on a silicon-depleted diet had depressed growth, retardation in 
skeletal development and, skull and connective tissue (combs, wattles and joints) deformations. Carlisle, 
197814. 
  
Figure 7 - Effect of silicon on rabbit elastic aortic tissues. Left image: The elastic fibres (white arrows) of a 
rabbit that received only a cholesterol diet. The fibres are mostly depleted, thin and fragmented. Right 
image: the elastic fibres of rabits that received a cholesterol diet with silicon  are dense, regular and often 
thickened. Loeper, 19783. 
  Aorta and aortic stiffness 2.2.1
 The aorta is one of the largest elastic arteries and has two main functions; 
firstly to carry oxygenated blood to the tissues of the body for their nutrition; and 
secondly to cushion the blood flow transforming the periodical left ventricular 
ejection into a continuous flow20. The cushioning function is only possible due to 
the arterial wall structure, which allows the vessel to act like an elastic buffer. 
Thus the structure of the aortic wall and its elastic behaviour is vital for  
cardiovascular performance21. 
 Aortic stiffness describes the reduce capability and capacity of the aorta to 
expand and contract in response to pressure changes, and therefore is closely 
14 
 
related to the mechanical properties (e.g. elasticity) of the arterial wall22 (Figure 8 
(b)). With aging, the aortic wall thickness and stiffness are increased due to 
structural changes in the intima and media layers, these include alterations in the 
elastin and collagen compositions, calcium deposition and increase of the intima-
media thickness22 (Figure 8 (a))21. 
 
Figure 8 - Aortic stiffness. a) Representation of a normal (upper) and stiff aorta (lower). Note the perfectly 
smooth appearance of the intima in the normal aorta, compared to the irregular nodules and the rough 
appearance of the stiff aorta. Adapted from Warfield, 192023. b) Schematic representation of the role of 
arterial stiffness in decreasing blood flow through the peripheral circulation. Briet, 201224. 
  Aortic extracellular matrix (ECM) and ageing 2.2.2
 Connective tissues are characterised by the amount, type and arrangement 
of their ECM components. In addition to providing the architectural framework 
for the arterial wall that imparts mechanical support and viscoelasticity, the ECM 
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plays an essential role in the development, remodelling and signalling in the 
cardiovascular system22. 
 The ECM of the aortic wall is composed of two main classes of 
macromolecules, fibrous proteins and glycoproteins, closely associated with the 
vascular smooth muscle cells (VSMC) that produce them. These molecules are 
organized into highly ordered networks that vary within the different layers of 
the aortic wall, intima, media and adventitia25. The tunica media is organized into 
lamellar units, which consists of concentric layers of elastic fibres, VSMC and 
interlamellar matrix25. Elastic fibres are composed predominantly of elastin, 
whereas the interlamellar matrix includes type I collagen, type III collagen and 
other ECM molecules such as glycoproteins, proteoglycans and 
glycosaminoglycans (or mucopolysaccharides)22, 25 (Figure 9).  
 
Figure 9 - In vivo arrangement of combined and individual constituents of the aortic ECM. 3D confocal 
images showing in vivo microstructure (a), in green: elastin (b), blue: VSMC nuclei (c) and red: collagen (d). 
Lumen surface located at top and aortic layers distributed from top to bottom: tunica intima, tunica media 
and tunica adventitia. O’Connell, 200826. 
 The two main components that account for the majority of aortic wall 
mechanical properties are the collagen and elastin fibres25.  
 Collagen type I and type III are the most abundant in the mature aorta. 
These collagen fibrils are known for their ability to self-assemble into highly 
orientated supramolecular aggregates forming a three-dimensional meshwork in 
the ECM that provides strength and resilience to the artery wall25, 27 (Figure 10). 
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Figure 10 - Collagen fibres in rat aorta. (a) Closer view of a collagen bundle in the rat aortic adventitia. Thin 
filamentous structures form the characteristic quarter-staggered appearance of collagen type I fibrils with 
the gaps separating consecutive tropocollagen monomers (arrow heads). (b) Tape-shaped collagen fibres in 
the rat aortic adventitia with thinner bundles or single collagen fibrils marked with the black arrow. Ushiki, 
200227. 
 Elastin is the major protein that imparts elasticity to the aortic wall and 
confers reversible extensibility during cyclic loading25. Elastin is a cross-linked 
polymer of the tropoelastin monomeric form of the protein. Elastin has an 
amorphous appearance by transmission electron microscopy and is the major 
component of mature elastic fibres27 (Figure 11 (b – c)). Elastin is formed through 
a highly complex process called elastogenesis (Figure 11 (a)). Inside the VSMCs, 
the elastin gene is activated and the protein tropoelastin is synthesized and 
released in the extracellular space. Once the tropoelatin is aligned with the 
microfibriliar lattice, most of the lysil residues will be deaminated and oxidized 
to allysine by the copper (Cu2+) requiring lysyl oxidase (LOX)25, 27. These allysine 
side chains can subsequently react with adjacent allysil or lysyl residues to form 
the elastin characteristic tetra-functional desmosine and isodesmosine cross-links, 
leading to the formation of an insoluble polymer that is the functional form of the 
elastin protein27. 
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Figure 11 - Elastic fibres synthesis and elastin network. (a) Schematic representation of elastogenesis. 
Tropoelastin molecules (green spheres) are released into the extracellular space and chaperoned (purple 
triangles) to the microfibrillar scaffold site. This association prevents the premature aggregation of 
tropoelastin. When it comes in contact with the microfibrillar structure the tropoelastin molecule is aligned 
correctly and modified by lysyl oxidase (blue cylinders) and incorporated in the elastic network by 
irreversible polymerization. Elastin, together with the microfibrils creates the elastic fibre. Adapted from 
Moore, 201228. (b) Closer view of an elastic fibre in the rat’s adventitia. The elastic fibre is seen as a bundle of 
fine fibrils. (c) Transverse section of the rat aortic media. The media elastic laminae (arrow heads) and 
interlaminar elastin fibres can be observed. Ushiki, 200227. 
 Mature elastin and collagen are extremely stable, and their turnover rates 
are so low that they are considered to last for the entire lifespan of the host25, 29. 
However, during aging and during the occurrence of vascular pathologies, the 
balance between proteases and their inhibitors is temporally destroyed29. 
Increased oxidative stress and expression of matrix metalloproteinases (MMP), 
such as MMP-2 and MMP-9, and proteolytic enzymes with “elastase-like” 
activity, have been reported to be involved in the thinning and degradation of 
vascular elastin and collagen fibres in ageing29, 30 (Table 1). 
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Table 1 - Proteinases and metalloproteinases (MMP) detected in vascular and inflammatory cells that 
participate in vascular ECM remodelling. Jacob, 200329. 
 
 Elastin expression, in most tissues, occurs only during late gestation until 
the end of childhood with negligible synthesis in adulthood. Thus, when the 
elastic fibres are damage during aging (or as a result of tissue injury); they are 
generally not repaired or replaced. Instead, more collagen is produced, 
decreasing the amount of elastin compared to collagen and shifting the arterial 
mechanical properties into the stiffer (100-1,000 times stiffer) range of collagen 
fibres27, 29.  
 The cumulative effects of the enzymatic degradation plus the structural and 
functional modifications of ECM components of the aortic wall during ageing, 
result in the degeneration and thinning of the elastin fibres with a gradual 
transfer of mechanical loading to collagen and in the increase of the microscopic 
calcification of the aortic media22, 25. 
  Silicon in the maintenance of aortic ECM 2.2.3
 The arterial wall is considered to be the main site of action for silicon in the 
aortic health. The potential involvement of Si in atherosclerosis was suggested 
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based on the remarks that the Si content in the aorta is higher than in other 
tissues and it decreases with ageing and the development of atherosclerosis and 
hypertension3, 13 (Figure 12 & Table 2). 
 
Figure 12 - Effect of age on rabbit tissue silicon levels. Values represent mean silicon levels of 18 rabbits 
expressed as part per million (ppm) dry weight of tissue. Carlisle, 19752. 
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Table 2 - Silicon and cardiovascular diseases. 
Author 
Publication 
Year 
Species Cardiovascular disease Study Findings 
 
Loeper3 1974 Humans Atherosclerosis 
Silicon concentration decreases in direct proportion to the severity of the 
atheromatous lesion 
 
Schwarz13 1975 Humans Coronary heart disease 
Inverse relation between silicic acid in drinking water and the 
prevalence of coronary heart disease in Finland 
 
Dawson31 1978 Humans 
Hypertension, 
Atherosclerosis 
Significant negative correlations between silicon levels in drinking water 
and mortality rates for hypertension and atherosclerosis. 
 
Nakashima32 1984 Humans Atherosclerosis 
Increase in arterial silicon content is related to the occurrence and/or 
progression of atherosclerosis 
 
Najda33 1991 Rats Atherosclerosis 
Increase in HDL-cholesterol and HDL-phospholipid concentrations and, 
decrease in LDL-cholesterol and triglyceride levels in the silicon 
supplemented group. 
 
Maehira34 2011 Rats Hypertension 
Silicon reduces hypertension in spontaneously hypertensive rats by 
stimulating intracellular Mg uptake and antihypertensive and anti-
atherogenic gene expressions. 
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 Loeper and Fragny observed that Si partially inhibits lipid deposition through 
the preservation of elastin fibres (Figure 7) and mucopolysaccharides integrity which 
enhances the impermeability of the vessel wall to lipid and calcium deposition3. 
Conversely, Nakashima measured the Si content of normal (healthy), fatty streaks 
and atheroma of human aortic intima and found an increased in the aortic intima Si 
content with the development of atherosclerosis, although no correlation was found 
between Si content and ageing32 (Table 2). The differences between these reports may 
originate from the different aortic tissue used for Si measurement. As only the intima 
layer was analysed in the studies by Nakashima, it is still possible that the Si content 
of the aorta as a whole, could decrease with the development of atherosclerosis as 
found by Loeper’s original study. 
 A structural role for silicon has also been proposed, mainly supported by the 
findings that in connective tissues, silicon is integrally associated with 
glycosaminoglycans and polysaccharides fractions, especially hyaluronic acid, 
chondroitin 4-sulfate and dermatan sulphate15, 35. The metabolic processes by which 
Si is assimilated and incorporated within glycosaminoglycans is not understood, but 
in a stereochemical point of view, it is plausible that Si may be incorporated as a 
mono- or disaccharide derivative during the polysaccharide synthesis15. 
Additionally, Si has been shown to play a role in the formation of the cross-links 
between collagen and proteoglycans, thus stabilizing the matrix molecules and 
preventing its enzymatic degradation36. These findings lead to the proposal that Si is 
covalently bound to the carbohydrate matrix, where it may play an important role in 
the structural organization of these molecules, functioning as a biological cross-
linking agent and holding the glycosaminoglycans and proteins together in an 
organized fashion15, 36.  
 
 The biochemical role of silicon in the connective tissue synthesis and 
maintenance of cardiovascular health has also been associated with in its aptitude to 
influence the biological availability, uptake, utilization, distribution and excretion of 
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metals, essential and toxic37. The metabolism of the different minerals are highly 
interdependent of each other, so it’s not surprising that Si, by affecting the uptake of 
one mineral, may promote major changes in the organism’s metabolic functions. 
Recent work have suggested that the association between silicon and connective 
tissue synthesis and function, including its effects on the integrity of the elastin and 
collagen fibres in the artery wall, may be due to the ability of Si to influence the 
metabolism of other essential metals, such as copper, iron and manganese, that are 
vital co-factors in enzymes involved in connective tissue synthesis and structure37, 38. 
 Silicon facilitates copper utilization and iron absorption and transportation38, 39. 
Copper and iron are crucial in the synthesis of elastin and collagen fibrils, acting as 
essential co-factors for the enzymes involved in the cross-link formation (LOX) and 
hydroxylation of proline residues (prolyl 4-hydroxylase) during collagen and elastin 
synthesis40 (Figure 11). Experimental and epidemiological studies on animals and 
man, have shown that Cu deficiency leads to the abnormal synthesis of elastin and 
collagen in arteries, thus damaging the elastic properties of the vessel wall41. 
Moreover, Si supplementation in calves and quails led to marginal increase in the 
calcium and phosphorous content of the tibia. It seems that silicon affects ECM in 
both tissues (bone and vascular tissues). In bone, which is naturally calcified 
interacts with Ca and P favouring the calcium incorporation into the bone, but in the 
aorta it prevents damage of the wall and prevents subsequent calcification42. 
 Aluminium accumulation influences the pathogenesis of Alzheimer’s disease 
and also interferes with the intracellular calcium homeostasis and enzymatic activity 
of several Mg and Fe dependent enzymes. Silicon interacts with aluminium species 
to form aluminosilicates reducing its gastro-intestinal absorption and enhancing its 
excretion via kidneys and therefore reducing its potential toxicity37. 
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2.3 Analytical techniques 
 Earlier studies investigating the silicon content of human aortas used 
colorimetric assays3, 32 that are prone to interference and it is unlikely that 
environmental contaminations were assessed13. 
 Total elemental analysis 2.3.1
 Silicon and other trace-elements concentration in the aorta were evaluated by 
inductively coupled plasma – optical emission spectrometry (ICP-OES); an analytical 
technique that is highly suitable for biological samples and one can obtain multi-
element information rapidly and accurately. The BMR group have extensive 
experience with this technique/method particularly for Si analysis. Prior to analysis 
the samples were converted into the liquid state through a digestion procedure: 
closed-vessel microwave assisted digestion (MWAD). 
2.3.1.1 Closed-Vessel MWAD 
 Biological samples, such as aortic tissue, have a very complex matrix composed 
of carbohydrates, proteins and lipids; and thus, not completely soluble in water or 
organic solvents. Sample digestion methods must therefore efficiently decompose 
the sample matrix to allow complete solubility of the biological matrix and the 
release the analyte(s) of interest.  
 Microwave-assisted acid digestion has become the favour method of 
preparation of samples for total elemental analysis. Some of the advantages of this 
technique include a higher temperature and pressure, which reduces the digestion 
time, use of ultra clean plastic ware (PTFE), which reduces the potential 
contaminants, reduction in acid volume and sample mass and a reduction in the loss 
of volatile species43. The single reaction chamber features a large, pressurized 
reaction chamber into which all samples were placed simultaneously for microwave 
digestion. The sample vials sit in a hydrogen peroxide solution that provides a 
consistent load for the delivered microwave energy. This insures even heating and 
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consistent conditions in all the sample vials, but it also soaks up energy from 
exothermic reactions. The chamber is pressurized with nitrogen to prevent the 
boiling of samples and to eliminate possible cross contamination43 (Figure 13). 
 
Figure 13 - Flow diagram of the single reaction chamber operation in the UltraWAVE™ microwave digestion 
system. Nóbrega, 201243. 
2.3.1.2 ICP-OES 
 ICP-OES is one of the most common techniques for elemental analysis. A 
plasma source is used to vaporise the sample into its constituent atoms or ions, 
further collisional excitation within the plasma promotes the transition of the outer 
electrons to a higher energy level. The energy absorbed by the electrons is released 
on return to the resting state by emitting photons of a characteristic wavelength 
depending on the element present (qualitative information) (Figure 14). The 
intensity of the radiation (energy) released is related to the number of transitions, 
which is proportional to the element concentration in the sample (quantitative 
information)44. 
 
Figure 14 - Schematic of an ICP-OES. A plasma source is used to excite the sample atoms to excite states; the 
intensity of the radiation emitted at specific wavelengths is measured and used to determine the concentrations 
of the elements of interest. 
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 One of the major advantages of ICP-OES is its capability for multi-element 
analysis. The ICP-OES at MRC-HNR has a polychromator attached for simultaneous 
analysis of up to ten elements, which can be analysed in the same amount of sample 
that is required to determine one element using a monochromator. This is ideal for 
biological samples, like the aorta specimens analysed in this work, where sample 
volume is limited. 
 Biochemical Assays for the Aortic Matrix 2.3.2
 The elastin content of the aortic specimens was analysed using a quantitative 
dye-binding method, developed based on the Fastin™ Elastin Assay. Collagen was 
determined using a colorimetric assay for hydroxyproline, after the removal of the 
elastin peptides present in the matrix by immunoprecipitation (IP). 
2.3.2.1 Elastin Quantification 
 Experimental procedures reported in literature were compared for elastin 
quantification. The following criteria were considered: I. Type of elastin measured 
(cross-linked and/or soluble); II. Detection limit; III. Accuracy of method; IV. Sample 
preparation; V. Interfering agents; and VI. Cost per analysis. The Fastin™ Elastin 
Assay was selected as a suitable method for elastin measurement in human aortic 
tissue. 
 The Fastin™ Elastin Assay is a quantitative dye-binding method for the analysis 
of soluble elastin peptides. Insoluble cross-linked elastin can also be measured by the 
extraction and reduction of this protein in the form of soluble cross-linked 
polypeptide elastin fragments (α-elastin) by hot oxalic acid treatment. The 
quantification of soluble α-elastin is based on the release of a bound elastin-specific 
dye, 5,10,15,20-tetraphenyl-21H,23H-porphine tetra-sulfonate (TPPS), that is firmly 
retained by the basic amino acid side chain residues of elastin (Figure 15). The 
presence of other soluble proteins or complex carbohydrates does not interfere with 
this assay. 
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Figure 15 - The visible absorbance spectrum and structural form of TPPS. 
2.3.2.2 Collagen Quantification 
 Hydroxyproline (OH-Pro) is an imino acid that is unique to collagen and 
elastin45, and is widely used as a factor to estimate the collagen content in biological 
samples. An immunoprecipitation step was combined with OH-Pro amino acid 
quantification assay to remove the elastin present the aortic ECM and accurately 
quantify the collagen content. 
 The determination of the hydroxyproline composition of a polypeptide consists 
of two steps: I. Complete hydrolysis of the tissue lysate proteins to liberate the 
residues; and II. Quantification of the free OH-Pro amino acids. 
2.3.2.2.1 Immunoprecipitation 
 Immunoprecipitation is a method that enables the purification of a protein 
from a complex mixture using a protein specific antibody immobilized on a solid 
support. The antibody is pre-immobilized onto an insoluble support, such as agarose 
beads, and then incubated with the tissue lysate containing the target protein. The 
immobilized immune complexes are collected from the lysate, eluted from the 
support and finally analysed. 
 For this project the elastin was immobilized using the Thermo Scientific Pierce 
Classic IP kit, via Protein A/G agarose beaded support coupled with a monoclonal 
anti-Elastin antibody (Figure 16). 
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Figure 16 - Diagram of the immunoprecipitation procedure. The antibody is captured in the agarose affinity 
beads. The incubation with the tissue lysate promotes the formation of the immune complex. Non-bound 
proteins, including collagen are eluted first, and finally the antibody and antigen are eluted with a low-pH 
buffer. 
2.3.2.2.2 Hydroxyproline composition assay 
Microwave-radiation induced hydrolysis 
 Microwave hydrolysis of proteins and peptides represent an accurate and 
convenient alternative to conventional methods. The microwave hydrolysis system 
at MRC-HNR is design to perform rapid, vapour phase acid hydrolysis of 
protein/peptide samples under inert, anaerobic conditions to prevent oxidative 
degradation of amino acids. Vapour-phase hydrolysis involves hydrolysis of a 
sample in a sealed, evacuated container also containing the hydrolysing acid 
(usually HCl), but where the sample is not place directly in the acid. The vacuum 
reduces the vapour pressure of the HCl, and thus resulting vapour that envelops the 
sample (Figure 17)46. 
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Figure 17 - Diagram of the hydrolysis reaction in the vessel for vapour-phase microwave hydrolysis. The 
sealed sample vessel containing the hydrolysing acid and the sample vials is alternately vacuum evacuated and 
purged with nitrogen. The acid vapour envelops the sample hydrolysing the peptides/proteins and liberating the 
amino acid residues. 
Hydroxyproline assay 
 The hydroxyproline is released upon acid digestion of the collagen containing 
tissue lysate. In the hydroxyproline assay, the free amino acid concentration is 
determined by the reaction of oxidized hydroxyproline with 4-
(Dimethylamino)benzaldehyde (DMAB), which results in a colorimetric (560 nm) 
product, proportional to the hydroxyproline content in the tissue lysate (Figure 18).  
 
Figure 18 - Diagram of the OH-Pro procedure. 1. Collagen was digested to free amino acids. 2. & 3. OH-Pro 
residues were oxidised with buffered chloramine-T reagent & the chromophore developed upon the addition of 
the Erlich’s Reagent. The hydroxyproline content was determined upon the absorbance measurement. 
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 The assay does not discriminate between types of collagen, pro-collagen or 
mature collagen. Note that proteoglycans do not interfere with the analysis because 
they only react with Erlich’s reagent after pre-treatment with acetyl acetone47. The 
total collagen content of the tissue lysate is determined assuming that this protein 
contains an average of 13.5% w/w of OH-Pro48. 
 
  
30 
 
3 Materials and Methods 
3.1 Materials 
 Unless stated otherwise all water used was ultra-high purity (UHP; 18.2 MΩ/cm) 
from a Sartorius Stedim Biotech arium® pro ultrapure water system. 
 High purity nitric acid, ≥69% (w/v) HNO3 (puriss. p.a., ACS reagent) was 
purchase from Sigma-Aldrich Company Ltd., Dorset, UK. 
 Samples were weight accurately on a four decimal place, top pan balance 
(Sartorius Ltd). 
 Atomic spectroscopy single elemental standard solutions were obtained from 
PerkinElemer Life and Analytical Sciences, Connecticut, USA (Pure Plus grade: Al, 
Ca, Cu, Fe, K, Mg, Mn and Zn; and Pure grade: B, P and Si) and SPEX CertiPrep, 
Inc., New Jersey, USA (Assurance grade: Na). 
1.1 Tissue samples 
 The tissue samples were obtained from Dr. Ian Wilkinson (Addenbrooke’s 
Hospital) through collaborations and he obtained the tissues from Addenbrooke’s 
Hospital and other hospitals in the East Anglia Region, UK. Ethic approval number 
MREC 03/2/074. 
 Aorta samples were selected from any patient deemed suitable for organ 
retrieval and where consent was obtained from the families. All specimens had 
grossly normal internal appearances except for a minority where calcification or 
plaques were clearly visible. Moreover, less than 5% had a diagnosed cardiovascular 
disease. The total number of the aortic wall samples collected amounted to 40, 21 
men and 19 females, with age ranged between 25 and 83 years, although the majority 
were within 45 – 79 years age range. 
3.2 Tissue collection/acquisition 
 Tissue samples where were obtained from cadaveric donors or beating heart 
donors through transplant co-ordinators at Addenbrooke’s Hospital (Cambridge, 
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UK). The aorta samples were cut lengthwise and carefully divided into smaller 
pieces/sections, preserved in tissue preservation fluid or available medium, and 
stored temporarily at -80⁰C. Upon ethical aproval, the samples were sent to MRC-
HNR for multi-element analysis and for biochemical analysis (collagen and elastin 
contents). 
3.3 Subsampling in the MRC-HNR laboratory 
 On receipt at the MRC-HNR laboratory the aorta samples were stored at -80⁰C 
until subsampling. All further sample preparation was carried out entirely in a 
laminar flow-hood cabinet (Class II Safety Cabinet, Walker, Glossop, UK). All metal 
and plastic surfaces were decontaminated and sterilized with Distel High Level 
Laboratory Disinfectant (Tristel Solutions limited, Snailwell, UK). 
 After thawing, the aorta samples where thoroughly rinsed with water to 
remove the preservative solution and remaining blood and if present, the 
surrounding adipose tissue was removed. The cleaned aortas were divided into 
small pieces: approximately 40 mg in weight for multi-element analysis and 10 mg in 
weight for biochemical testing, and stored at -80⁰C until analysis. All aliquots were 
carefully sliced so as to maintain all three aortic layers, tunica intima, tunica media 
and tunica adventitia, intact in all samples. The aorta samples with visible lesions, 
i.e. calcified plaques or wall thickening, where removed and aliquots of the normal 
and lesion areas analysed separately. 
 In a few cases the sample size was insufficient for the biochemical analysis of 
the ECM components, therefore analysis for elastin content was not carried out. 
3.4 Elemental Analysis 
 The aortic wall element concentrations of Al, B, Ca, Cu, Fe, K, Mg, Mn, Na, P, Si 
and Zn in the aortic samples was determined by inductively coupled plasma optical 
emission spectrometry (ICP-OES) using the multi-element analysis mode (Jobin 
Yvon Horiba – ULTIMA 2000-2 with a polychromator attached).  
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 For element determination, samples were decomposed according to the 
following procedure: 40 mg of wet samples were freeze dried overnight (Mini 
Lyotrap, LTE scientific Ldt, Greenfield, Oldham, UK) until reached constant weight. 
The freeze dried samples were accurately weighed to determine the water content 
and then digested using a closed-vessel microwave assisted acid digestion (MWAD) 
system (Milestone UltraWAVE™) and Si-free, pre-cleaned standard 
polytetrafluoroethylene (PTFE) vials with 400 μL 35% (v/v) nitric acid (HNO3). The 
microwave heating program was performed in three steps: (1) 5 min ramp from 23⁰C 
to 120⁰C; (2) 5 min ramp from 120⁰C to 230⁰C; and (3) 10 min at 230⁰C; followed by a 
cooling step for 20 min. The microwave power was limited to a max of 1000 W and 
pressure was limited to a maximum of 150 bar. All samples were digested to 
completeness and then diluted 1:2 with UHP water for the quantification of Al, B, 
Cu, Fe, Mn, Si and Z; and 1:10 in UHP water for the quantification of the remaining 
elements: Ca, K, P, Mg and Na. Blanks for the control of the digestion process and a 
certified reference material (Seronorm™ Trace Elements Serum L-1) for quality 
control were prepared in a similar manner and analysed collectively with the 
samples. The ICP-OES running conditions for the digested aorta sample analysis are 
summarized in Table 3. 
Table 3 - Running conditions of ICP-OES for the analysis of aorta samples. 
Analytical Conditions  
RF power (W) 1000 
Plasma gas (L min-1) 10 
Sheath gas (L min-1) 2 
Auxiliary gas (L min-1) 0.0 
Speed pump (rates min-1) 8 
Nebulisation flow rate (L min-1) 0.02 
Plasma stabilization time (s) 10 
Number of replicates 3 
 Multi-element standards were prepared from individual 1,000 ppm aqueous 
stock solutions, with final concentrations for each element ranging from 0 to 10 ppm 
in an acid solution matched to the digested samples, i.e. 17% (v/v) HNO3 for the 1:2 
33 
 
diluted digest samples and 0.17% (v/v) HNO3 for the 1:10 diluted digest samples 
(Table 2). Peak profiles were used for each measurement run and the polychromator 
was centred in the Mg wavelength. Drift check solutions were carried out after every 
block of approximately 10 samples. 
Table 4 - Atomic spectroscopic information for the multi-element analysis of aorta samples by ICP-OES. 
Description of the chromator type, the measured emission wavelength, diluent type and standard range used in 
the analysis of each element.  
Element Chromator Type 
Wavelength 
(nm) 
Diluent type 
(% HNO3) 
Standard range 
(ppm) 
Al Polychromator 396.152 0.17 0-10 
B Polychromator 208.959 0.17 0-5 
Ca Polychromator 317.933 17 0-10 
Cu Polychromator 324.754 0.17 0-5 
Fe Polychromator 259.940 0.17 0-5 
Mg Polychromator 279.079† 17 0-10 
Mn Polychromator 257.610 0.17 0-4 
Zn Polychromator 206.191 0.17 0-5 
P Polychromator/Monochromator‡ 213.618/177.440 17 0-10 
Si Monochromator 251.611 0.17 0-5 
K Monochromator 766.490 17 0-10 
Na Monochromator 589.592 17 0-10 
†Polychromator centring wavelength.  
‡ Due to peak shift problems for the P peak when using the polychromator, some samples were analysed using 
the monochromator system for this element. 
 Matrix effect was corrected using pooled sample-based standards (PSBS)49. 
Briefly, after elemental analysis the remaining volume of the digested samples were 
pooled into a new tube. Aliquots of the pooled samples were spiked with different 
concentrations of the multi-element standard solutions, previously prepared, 
maintaining a sample dilution of 1:2. 
 As a ubiquitous element, and despite the careful sample handling, diluent 
(HNO3) and environmental contamination with Si and some other trace elements is 
highly likely and it may vary between batches49. Thus, the limits of quantification for 
the samples were restricted by the background levels of the elements analysed in 
each batch:                           . 
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 Element concentration was measured in mg or μg of dry sample mass and 
corrected for matrix effect. 
3.5 Biochemical assays 
 Elastin solubilisation and protein extraction 3.5.1
 For the method development work, see chapter 4.II Method development for 
“combined” elastin and collagen quantification. 
 The insoluble matrix elastin in the aorta sample was solubilized to α-elastin50 
and the collagenous protein extracted as gelatine51 by hot oxalic acid treatment. The 
10 mg aorta aliquots previously prepared (see section 3.4) were freeze dried 
overnight (Mini Lyotrap, LTE scientific Ldt, Greenfield, Oldham, UK) until reached 
constant weight. The dried material was accurately weight and homogenized with 
an electric homogenizer (Tissue Tearor Homogenizer 120 VAC), speed 4 for 1 min at 
room temperature in 1 mL 0.25 M oxalic acid. The suspension was further incubated 
in a heating plate at 98⁰C for 1h. The supernatant (OAE) containing solubilized α-
elastin and collagen as gelatine was collected by centrifugation at 11,000xg for 20 
minutes. The residual tissue in the tube was further incubated with 0.5 mL 0.25 M 
oxalic acid, at 98⁰C for 1h. Up to three extractions were required to completely 
solubilize the insoluble elastin present in the aortic ECM. The first, second and third 
OAEs were pooled together (OAEp); a fourth extract was analysed separately to 
establish if the solubilisation was complete, i.e. the absence of (or negligible levels of) 
elastin in the fourth extract using the Fastin™ Elastin Assay (see below, section 3.6.2). 
 Aliquots of the pooled extracts, OAEp, were analysed for total elastin and 
protein contents (see below, section 3.6.2 & section 3.6.3). An additional aliquot of 
the OAEp was immunoprecipitated to separate the elastin and collagen components 
and re-analysed for elastin and collagen contents (see below). 
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 Elastin Quantification 3.5.2
 The OAEp solutions obtained in section 3.6.1 were analysed for aorta total 
elastin content, i.e. soluble tropoelastin and mature insoluble elastin; using the 
Fastin™ Elastin Assay kit (Biocolor Ltd, Antrim, UK)52. This assay only detects elastin 
and is unaffected by collagen present in the OAEp. 50 μL aliquot of the pooled OAE 
and 500 μL aliquots of for the fourth OAE were incubated for 10 minutes in an ice 
bath and then treated with an equal volume of elastin precipitating reagent 
containing trichloroacetic acid and hydrochloric acid, for 15 min at 4⁰C. Following 
precipitation of the elastin peptides, the mixture was centrifuged at 10,000xg for 10 
min and the supernatant discarded. The recovered sample was incubated with 1.0 
mL of Fastin™ dye reagent, containing TPPS, for 90 min at room temperature with 
constant agitation. The elastin-dye complex was then precipitated via centrifugation 
at 10,000xg for 10 min. The supernatant was discarded and the dye released by 
adding 250 μL of dissociation reagent containing guanidine-HCL and propan-1-ol. 
The final dye solution was placed in a 96-well plate and the optical density was 
measured at 540 nm using a microplate reader (Labsystems Multiskan RC, Artisan 
Scientific, Champaign, IL, USA).  
 The elastin content was calculated from a standard curve produced with α-
elastin standards (elastin from bovine neck ligament; Sigma-Aldrich Company Ltd., 
Dorset, UK), with concentrations between 5 to 70 μg, treated with the same method 
as the samples. Elastin content was expressed as mg elastin/g dry tissue weight. 
 Protein Quantification 3.5.3
 Total protein concentration was determined using the Non-interfering Protein 
Assay™ Kit (NIPA) (Calbiochem®, Merck KGaA, Darmstadt, Germany). Total protein 
content was used to calculate the volume of OAEp to be loaded in the 
immunoprecipitation column (see below, section 3.6.1). The assay was performed 
according to the manufacturer’s protocol with minimal alterations. Briefly, the 
interfering agents were removed by adding 500 μL UPPA-I and 500 μL UPPA-II 
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reagents to a 50 μL aliquot of OAEp. The precipitated protein was immobilized by 2 
cycles of centrifugation at 11,000xg for 5 minutes each, and the interfering agents in 
the supernatant were discarded. The pellet was dissolved with 400 μL UHP water 
and the protein content was assayed by mixing the sample with 100 μL of an alkaline 
solution containing a known concentration of copper salt (Reagent-I). The unbound 
copper in solution (unbound to the protein backbone) was rapidly mixed with 1.0 
mL of a colouring reagent (Reagent-II) and incubated in the dark for 15 min at room 
temperature. Finally, 250 μL of the solution were transferred to a 96-well plate and 
the optical density measured at 490 nm, against water, in a microplate reader. 
 A series of Bovine Serum Albumin protein standards (STD) were prepared in a 
similar manner, with a protein content ranging from 0 to 50 μg.  A standard curve 
and corresponding linear regression were calculated by plotting log(A490STD 0μg/A490STD) 
vs protein amount. Total protein amount in the samples tested was calculated by 
comparison of the log(A490STD 0μg/A490Sample) with the BSA protein standards.  
 Immunoprecipitation 3.5.4
 For the method development work, see chapter 4.II Method development for 
“combined” elastin and collagen quantification. 
 An aliquot of the OAEp underwent immunoprecipitation to separate the 
collagen and elastin components, as elastin will interfere with the collagen analysis. 
Unless stated otherwise all centrifugation steps were performed at 1,000xg for 1 min, 
and all the incubations were performed at 4⁰C with gentle end-over-end mixing. 
 For the capture of the elastin proteins solubilized to α-elastin in section 3.6.1, 
100 μL of the pooled OAE was neutralized to pH 7-8 with 1M NaOH. The sample 
was then further diluted with 2x TBS Buffer for a final protein content of between 30-
50 μg, as determined with the NIPA™ assay (see section 3.6.3). Prior to analysis a 
pre-clearing step was conducted to remove any proteins and ligands that bind non-
specifically to the beaded support. Briefly: 80 μL of Control Agarose Resin slurry 
was incubated with 300 μL of the neutralized OAEp solution for 1 hour. The flow-
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through was collected by centrifugation of the spin column into a new collection 
tube. 
 The immunoprecipitation procedure was carried out in four steps, using the 
Pierce® Classic IP Kit (Thermo Fisher Scientific Inc., Rockford, USA): 
I. Antibody capture in agarose beaded support: 7 μg of the specific [10B8] 
anti-elastin antibody (Abcam, Cambridge, UK), 30 μL of Pierce Protein A/G 
Agarose resin slurry and 150 μL of 1x TBS Buffer were incubated in a spin 
column for 5 hours at 4⁰C. The flow-through was collected and analysed 
for protein content (section 3.6.3) to confirm the successful binding of the 
antibody to the agarose beads. 
II. Formation of the immune complex: 250 μL of the pre-clear solution was 
added to the complex agarose beaded support-antibody and incubated 
overnight (15-17 hours) at 4⁰C.  
III. Elution of the collagen and proteins fraction: all non-elastin proteins, 
including collagen, were collected by centrifugation of the non-antibody-
bound fraction. The resin was further washed three times with 1x TBS 
Buffer and finally with 100 μL of conditioning buffer.  
IV. Elution of the immune complex: the spin column was incubated in a 
heating plate with 100 μL of elution buffer for 10 minutes at 70⁰C with 
gentle mixing. The immune complex was collected through centrifugation 
of the eluate. 
 The collagen and protein fractions collected at step III were analysed for elastin 
content by the Fastin™ Elastin Assay (see section 3.6.2) to verify that the IP was 
successful, i.e. no elastin should be detected in the collagen/proteins fraction; and the 
collagen content was estimated by a hydroxyproline assay (see below, section 3.6.5). 
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 Chicken tendon was used as a positive quality control of the 
immunoprecipitation assay, and was carried out simultaneously with the aorta 
samples. 
 Collagen quantification 3.5.5
 A hydroxyproline (OH-Pro) assay was used to estimate the total amount of 
collagen in the aorta matrix. The eluted fractions collected in section 3.6.4 – step III., 
containing collagen and other matrix proteins, were pooled together and freeze 
dried for 48 h to concentrate the protein amount. The residue obtained after freeze 
drying was hydrolysed by vapour phase HCl in a microwave digestion system 
(CEM Discover System, Matthews, Nc, USA). The digestion was carried out under 
inert, anaerobic conditions (15 psig nitrogen pressure); at a constant temperature of 
150⁰C and 150 W for 15 min. Vapour phase HCl was generated from 10 mL 6M HCl 
added into the reaction vessel. 
 The hydrolysed samples were reconstituted with 50% isopropanol and 
carefully transferred into eppendorf tubes. In a 96-well plate, 10 μL of sample or 
standard solution was mixed with a buffered chloramine-T reagent and the 
oxidation was allowed to proceed for 5 min at room temperature. The chromophore 
was developed with the addition of 0.1 mL Erlich’s Reagent followed by incubation 
for 30 min at 60⁰C53. The absorbance was measured at 540 nm in a microplate reader. 
The hydroxyproline content was determined by comparison with trans-4-hydroxy-L-
proline standards (Sigma-Aldrich Company Ltd., Dorset, UK) prepared in the 
concentrations range 0 to 0.5 mg/mL.  
 Gelatine (Sigma-Aldrich Company Ltd., Dorset, UK) was used as a quality and 
positive control for the OH-Pro assay, and was carried out simultaneously with the 
samples. 
 Total collagen content was expressed as μg of collagen per mg dry weight, 
assuming that collagen contains an average of 13.5% w/w OH-Pro48. 
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3.6 Statistical analysis 
 The statistical analysis was carried out using the GraphPad Prism statistical 
package (version 5.04 for Windows, GraphPad Software, San Diego California USA).  
All measurements were performed at least in duplicates (n ≥ 2). Experimental results 
are shown as mean ± SD and, where appropriate medians and ranges, are also 
presented. The ROUT algorithm of the GraphPad software for outliers was used on 
all datasets to identify potential outliers. 
 The normality of the variables was tested via D'Agostino & Pearson omnibus 
normality test. Because not all the variables were normally distributed, and due to 
the variable sample size and small age distribution of the subjects, non-parametric 
test were carried out for all statistical analysis. For comparison of the elemental 
contents between genders a non-parametric two-tailed t test: Mann-Whitney test, 
was used. Spearman correlation coefficients were calculated between aorta element 
concentrations with age or gender. Associations with BMI were also investigated as 
some subjects were overweight and this is a known risk factor for cardiovascular 
diseases. Linear models were fitted to the data. Subgroup analyses were performed 
only if the interaction was significant. The level of significance was set at P < 0.05.  
 Element concentrations below the limit of quantification were not rejected, or 
changed, so that the distributions would not be distorted, which is important for 
correlation analysis and calculation of median values. 
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4.I Mineral and biochemical study of human aortas 
4.I.1 Results 
4.I.1.1 Population characteristics 
 Baseline characteristics for the study population are presented in Table 5. 
Overall 40 aorta specimens were collected from 21 male and 19 female organ donors. 
Median age, BMI and water content were similar for male and female subjects.  
Table 5 - Descriptive characteristics of the healthy organ donors. 
 Males (n = 21)  Female (n = 19) 
 Mean ± SD Median Range  Mean ± SD Median Range 
Age (years) 59 ± 13.4 64 25 – 79  66 ± 7.9 64 54 – 83 
Weight (kg) 80 ± 8.1 80 62 – 90  74 ± 21.5 68 50 – 130 
Height (m) 1.72 ± 0.09 1.72 1.58 – 1.83  1.60 ± 0.06 1.59 1.45 – 1.73 
BMI (kg/m2) 27.3 ± 3.5 27.4 21.6 – 36.1  27.8 ± 6.6 26.7 19.7 – 45.0 
Water† (%) 71.4 ± 4.5 72.2 61.7 – 78.7  73.6 ± 4.3 74.8 67.0 – 82.4 
†Calculated as percentage of the difference between the initial and the freeze dried sample weight. 
 As previously mentioned (see Materials and Methods, section 3.4) the aortas 
were generally from healthy individuals, but less than 5% had a diagnosed 
cardiovascular disease. Indeed, discernible aortic lesions were observed in three 
aorta samples. Two presented visible calcified areas (Figure 20 (c) & (d)). The other 
specimen showed no signs of calcified plaques, but revealed clear changes in the 
aortic wall with increased arterial wall thickness (Figure 20 (b)), one of the 
recognized indicators of aortic stiffness. Lesion areas were analysed separately for 
elemental composition (Appendix A). 
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Figure 19 - Representation of a normal looking aorta (a) and aortas with discernible wall lesions (b-c). b) Aorta 
with increase wall thickness and luminal enlargement characteristic of a stiffened aorta. c) & d) Aorta displaying 
calcified plaques, d) Close-up view of the calcified area and plaque (red arrow) in the aortic wall. 
4.I.1.2 Aorta mineral composition 
 Table I.2 shows the results of the metallomic study of the aorta specimens by 
ICP-OES. The trace-elements B, Mn and Si were only detected in 60, 48 and 90%, 
respectively, of the 40 samples analysed. The mean concentrations of the elements 
found are shown in Table 6 with relevant values from literature (see discussion). 
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Table 6 - Essential and trace-element concentrations (per dry tissue weight) in human aorta specimens 
analysed in this study with reference values from literature population studies. 
 Units 
All subjects  Reference 
Mean ± SD Range n  Mean Age range n Year 
Al μg/g 8.3 ± 3.0 3.48 – 14.27 21†  10 55 - 92 26 200054 
B μg/g 6.8 ± 4.9 0.38 – 22.7 24  n.a    
Cu μg/g 4.1 ± 2.2 1.16 – 13.86 39  4.35 ‡ 16 - 80 200 198755 
Fe μg/g 45.7 ± 27.9 15.0 – 118.2 40  125 55 - 92 26 200054 
Mn μg/g 1.1 ± 0.4 0.11 – 1.79 17  n.a    
Si μg/g 14.1 ± 11.7 0.75 – 44.8 35  12.5 55 - 92 26 200054 
Zn μg/g 70.9 ± 19.4 29.7 – 125.1 40  85.0 ‡ 16 - 80 200 198755 
Ca mg/g 9.3 ± 5.2 2.64 – 23.81 40  10.25 0 - 99 71 199756 
K mg/g 7.1 ± 5.1 0.71 – 16.9 22†  4.06 72 1 198557 
Mg mg/g 0.9 ± 0.4 0.26 – 2.23 40  0.81 20 - 40 20 201158 
Na mg/g 6.2 ± 4.4 1.76 – 17.1 22†  n.a    
P mg/g 3.4 ± 1.3 1.01 – 6.90 40  11.49 0 - 99 71 199756  
†Only 22 aorta samples were analysed for Al, K and Na content  
‡Values corrected for matrix effect 
n.a: data not available 
Age- and gender-related alterations 
 Correlations with age and gender were studied for the different elements 
studied in the aortas and these are shown in Table 7. Significant (P-value < 0.05) 
gender-related distributions in the elements concentrations were found for Cu and 
Na (Figure 21). Age-related changes in these elements (Cu & Na) were investigated 
between genders (Figure 22). For the other elements, as there were no gender 
differences in concentrations, male and female data were combined to investigate 
correlation with age. 
 Significant age-dependent alterations in the elements concentrations were only 
found for Al, Ca and P (Figure 23). See Appendix B for other (non-significant) 
associations with age and gender. 
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Table 7 - Correlation with age and gender for the different elements in the aortic wall. 
 
Age interaction 
 Association with age 
 
Association with gender 
Male vs Female 
  Male  Female Male  Female 
 r2† P-value†  r2† P-value‡  r2 P-value  Mean ± SD  Mean ± SD P-value‡ 
Al 0.802 0.003  ND ND  ND ND  8.70 ± 3.1  7.67 ± 2.9 0.538 
B 0.378 0.069  ND ND  ND ND  5.52 ± 3.2  7.70 ± 5.8 0.151 
Cu 0.251 0.055  0.051 0.827  0.396 0.103  3.39 ± 1.3  5.03 ± 2.7 0.023 
Fe 0.433 0.008  ND ND  ND ND  44.2 ± 24.8  52.9 ± 39.1 0.989 
Mn 0.049 0.428  ND ND  ND ND  0.94 ± 0.56  1.22 ± 0.25 0.093 
Si 0.188 0.280  ND ND  ND ND  12.5 ± 8.5  15.9 ± 14.5 0.779 
Zn -0.008 0.962  ND ND  ND ND  67.4 ± 18.2  74.8 ± 20.5 0.432 
Ca 0.336 0.034  ND ND  ND ND  9.23 ± 5.43  9.46 ± 5.1 0.871 
K 0.235 0.293  ND ND  ND ND  8.52 ± 4.8  4.53 ± 4.8 0.260 
Mg 0.126 0.466  ND ND  ND ND  0.85 ± 0.32  0.76 ± 0.33 0.278 
Na -0.226 0.312  - 0.286 0.321  - 0.464 0.243  4.63 ± 3.6  9.04 ± 4.33 0.011 
P 0.320 0.044  ND ND  ND ND  3.59 ± 1.4  3.14 ± 1.3 0.330 
†P-value and Spearman’s correlation coefficient (r2) indicates whether the parameter varies with age independent of gender (Spearman’s correlation). 
‡P-value indicates whether the parameter varies between gender independent of age (Mann-Whitney t test). 
ND – not determined 
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Figure 20 - Gender distribution of Si, Cu and Na in the human aorta samples. Data is shown as box-plots, 
where the horizontal lines indicate 10th, 25th, 50th (or median), 75th and 90th percentiles; the plus signal shows the 
mean, n represents the number of subjects. Female vs Male: *P-value = 0.023; **P-value = 0.011 (Mann-Whitney t 
test). 
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 Despite the differences in mean Cu and Na concentrations between genders, no 
significant age-related variations in these elements were observed for either males or 
females separately or when combined (Figure 22). Furthermore, by separating the 
data between genders, the number of subjects per group decreases and no 
conclusion can be made from the analytical test. 
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Figure 21 - Association of age for Cu (a) and Na (b) levels in the aorta samples from male and female subjects. 
Concentrations are represented for each subject and the dashed lines show the correlations with age. The thin 
horizontal dotted line shows the mean concentration for the element. Outliers are highlighted in red and were 
not included when carrying out the correlations. Spearman’s correlation coefficients (r2) and P-value are shown. 
 A strong exponential positive relationship between Al concentrations in the 
aorta and age was found (Figure 23 (b)). Other statistically significant positive 
associations with age were found for Fe, Ca and P (Figure 23 (c-e)). In this study, Zn 
levels were found to not vary with age (Figure 23 (f)). Silicon content did not vary 
significantly with age, although there appears to be an increase with age (Figure 23 
(a)). 
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Figure 22 - Changes in Si (a), Al (b), Fe (c), Ca (d), P (e) and Zn (f) concentrations in the aorta. Concentrations 
are represented for each subject and the dashed lines show the correlations with age. The thin horizontal dotted 
line shows the mean concentration for the element. Outliers are highlighted in red and were not included when 
carrying out the correlations. Spearman’s correlation coefficients (r2) and P-value are shown. Note: removing the 
value at 25 years did not affect the correlation shown. 
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4.I.1.3 Aorta structural composition 
 Elastin concentration in the aortic wall was determined in 39 of the 40 
specimens collected, with an average of 225.1 ± 62.8 mg per g dry weight.  
 Differences in elastin content and correlation with age (male plus female 
samples) are displayed in Figure 24. Mean elastin concentrations did not differ 
between males and females (Figure 24 (a)). The elastin content of the aortic walls did 
not significantly change with ageing. Although a slight decrease in the elastin 
concentration after 66 years was observed (Figure 24 (b)).  
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Figure 23 - Association of elastin with gender (a) and with age (b). a) Data is shown as box-plots, where the 
horizontal lines indicate 10th, 25th, 50th (or median), 75th and 90th percentiles; the open square show the mean, n 
represents the number of subjects. Elastin content did not correlate with gender (Mann-Whitney t test: P-value = 
0.989). b) . Concentrations are represented for each subject and the dashed lines show the correlations with age. 
The thin horizontal dotted line shows the mean concentration for the element. The vertical dashed blue line at 66 
years is only indicative. Spearman’s correlation coefficients (r2) and P-value are shown. 
4.I.1.4 Elemental and structural interactions 
 Correlations between aorta element concentrations with elastin concentrations 
and with BMI were investigated. There were 13 statistically significant correlations (r 
> 0.500, p < 0.05 and n > 15) of the total 225 tested (Note: these are tabulated in 
Appendix C). However, the relevant interactions are shown in Figure 25, 26 and 27.  
Copper and sodium correlations are gender dependent (Figure 26), as significantly 
different mean concentrations were found between genders (Table 7). No correlation 
was found between BMI and element levels or BMI and elastin content. 
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Element vs Element 
 There were statistically significant positive correlations between Ca and P 
concentrations in the aorta, and between the following elements: Al and Ca, Al and 
P, Al and Mg, Mg and Ca, Mg and P and B and Zn (Figure 25). The strongest 
correlation coefficient was found between Ca and P. Relatively close correlations 
were found between Al – Ca and Al – P and, Mg – Ca and Mg – P, respectively. 
Notably, no significant correlations between Si and Al or, between Fe and Al were 
observed. While not significant, a negative correlation was obtained between Si and 
P levels in the human aorta (Figure 25 (b)). 
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Figure 24 - Correlations between element concentrations in the human aorta samples. a) Si vs Al, b) Si vs P, c) 
Si vs Ca, d)Ca vs P, e) Al vs Ca, f) Mg vs Ca, g) Al vs Mg, h) Zn vs B and i) Fe vs Al. Outliers are highlighted in 
red and were excluded from the fitted linear model. Spearman’s correlation coefficient (r2), corresponding P-
value (ρ) and number of data points excluding the outliers (n) are shown. 
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 Statistically significant correlations were also found between Cu and Si and, Cu 
and Mg in female and between Cu and Zn in male aorta samples (Figure 26 (a - c)). 
A strong negative correlation was found between Na and K in the male aorta 
samples (Figure 26 (d)). Silicon levels in the aorta were not significantly correlated to 
any element with the exception of Cu in female aorta samples (Figure 26 (a)). 
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Figure 25 - Correlations with Cu and Na concentrations of the human aorta samples. a) Si vs Cu in females, b) 
Mg vs Cu in females, c) Zn vs Cu in males and d) Na vs K in males. Outliers are highlighted in red and were 
excluded from the fitted linear model. Spearman’s correlation coefficient (r2), corresponding P-value (ρ) and 
number of data points excluding the outliers (n) are shown. 
Element vs Elastin 
 Three statistically significant correlations were found between the element and 
elastin concentrations in the aorta samples. The strongest correlation (r2 = -0.615, P = 
0.009) was obtained between elastin and copper in samples from the female donors 
(Figure 27 (f)). Interestingly, a positive correlation was found between elastin and Cu 
concentrations in the samples from the male donors, but with less significance (r2 = 
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0.455, P = 0.038). K and Na concentrations were also correlated with the elastin in the 
human aorta, but in opposing directions (Figure 27 (b) & (c)). Elastin levels did not 
correlate with the Si, Zn or Ca concentrations in the aorta samples. 
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Figure 26 - Correlations between elastin and elements concentrations in the human aorta samples.  a) Elastin 
vs Si, b) Elastin vs K, c) Elastin vs Na in all subjects, d)Elastin vs Zn,  e) Elastin vs Ca, f) Elastin vs Cu in females 
and g) Elastin vs Cu in males. Outliers are highlighted in red and were excluded from the fitted linear model. 
Spearman’s correlation coefficient (r2), corresponding P-value (ρ) and number of data points excluding the 
outliers (n) are shown. 
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4.I.2 Discussion 
 The distribution of silicon in animal tissues and the nature of the Si interactions 
with ECM components, have led to the supposition of an essential role for Si in 
vascular health. As to enlighten possible associations between silicon and aortic 
health, the aim of this project was to determine the age- and gender-related changes 
in silicon levels of the human aorta, and to assess if these changes can be correlated 
with changes in elastin content. Silicon levels in the aorta samples were not found to 
vary significantly with age or with gender. The silicon concentration in the aorta was 
not significantly correlated to any element with the exception of Cu in female aorta 
samples, and although not significant, a negative correlation was obtained between 
Si and P levels. Moreover elastin levels did not correlate with the Si concentrations in 
the aorta samples. 
 One of the challenges experienced when performing this study was obtaining 
representative samples of a normal healthy population. Moreover, with the 
increasing life expectancy observed in the past century, acquiring a wide age range 
from both female and male donors was even more problematic. In this study, the 
mean age of the donors was ≥ 59 years and the majority were not diagnosed with a 
cardiovascular disease ( > 95%). Additionally BMI values were within the reported 
mean of the UK adult population59 (BMI: men = 27.2 kg/m2; women = 27.1 kg/m2). 
Still, the small number of samples and the low age range of the population studied 
should allow a critical analysis of the levels of Si, other elements and elastin in the 
human aorta. 
 Since the first published paper in 1974 by Loeper et al.3 suggesting a protective 
role for Si in aortic health, only one study has measured the silicon content of the 
human aorta. Minami and colleagues54 determined the Si levels (and other elements) 
in five human arteries. The aorta Si concentrations found in this study (14.1 μg/g dry 
weight) is similar to the results reported by Minami’s group (12.5 μg/g dry weight). 
Earlier studies suggested the potential involvement of Si in aortic health based on 
observations in which the Si content in connective tissues, especially the aorta, were 
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richer than other soft tissues3, 14. Little is known about the Si content in human soft 
tissues, with the exception of blood16 (0.037 – 0.377 μg/g wet wt) and women breast 
tissues60 (64 μg/g dry wt). In this study, the Si content found in the aorta was 35% 
lower than that reported in human breast tissues. Moreover, the human aorta was 
previously reported to have the lowest Si level among human arteries54, aorta (12.5 
μg/g dry wt) < basilar < femoral < coronary < radial (115 μg/g dry wt). Minami’s 
results suggest that high Si levels are, in fact, found in connective tissues, such as 
arteries, compared with soft tissues, e.g. human breast. However, Carlisle14 proposal 
that the highest Si concentrations are found in the aorta should be re-evaluated, as 
low Si levels were observed in the present study compared to the Si levels found in 
human breast tissue and radial arteries. 
 Some studies assessing the concentration of silicon in humans have 
demonstrated a decrease of silicon concentration with age3, 61 and associations 
between silicon and endocrine balance17, 18. Distinctive associations between bone 
mineral density in post-menopausal women, compared with pre-menopausal 
women and post-menopausal women taking hormone replacement therapy18; 
suggested that the hormonal effect on Si is associated with tissue incorporation and 
cellular utilization of this element. Older men and post-menopausal women (< 54 
years) were investigated in this study, thus it was not surprising that no age 
dependent or gender-related behaviour was found for the silicon concentrations in 
the aortic wall.  
 The aorta and other large elastic arteries progressively stiffen throughout life in 
a process called arteriosclerosis. Aortic stiffness is largely determined by the aortic 
wall structure, especially by the modification, natural (ageing) or induced (disease), 
of ECM components, namely elastin and collagen fibres20. When expressed as the 
tissue dry weight, the elastin concentration ranged between 135.1 to 355.1 mg/g, with 
a mean of 225.1 mg/g. The elastin values are in agreement with those observed in the 
human aorta for the same age range (50 – 90 years), where values between 113 – 371 
mg/g62, 63 have been reported.  
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 The analysis of the elastin burden in the whole aorta (i.e. all three layers: 
intima, media and adventitia present) revealed no age-related changes, although a 
slight visual descending trend was observed for older subjects (< 66 years). There is 
no consensus in literature as to whether the concentration of elastin increases or 
remains unchanged in the ageing aorta62, 63. Cattel and colleagues62 have highlighted 
the need to distinguish between changes in the absolute amount of a tissue 
component (per length) versus changes in its concentration (per mass). In Cattel’s 
study, aortic elastin concentrations increased with age, whilst the absolute amount of 
this protein decreased. Conversely, Spina and co-workers63 have reported a decrease 
in the elastin concentrations and the maintenance of a constant amount of elastin in 
the ageing aorta. These conflicting observations are possibly related to the different 
methodologies used by the different groups. In fact, Spina determined the elastin 
content through quantification of the elastin specific cross-linking residues 
(desmosine and isodesmosine) that have been recurrently shown to decrease with 
senescence64, 65; suggesting that changes in the elastic properties and stiffening 
observed in the ageing aorta may not be due to the degradation of the elastin in 
itself, but to alterations in the structure of the protein network. 
 In addition to the proteolytic mechanisms, the structure of elastic fibres in 
ageing tissues may also be altered by calcification. Calcium accumulates in the 
ageing blood vessel walls and is strongly bound to the microfibrillar component of 
elastic fibres22. Loeper and Fragny observed that Si partially inhibits lipid deposition 
through the preservation of elastin fibres and mucopolysaccharides integrity which 
enhances the impermeability of the vessel wall to lipid and calcium deposition3. 
Despite evidence of increased calcification in the ageing aorta (Ca/P vs age: P > 
0.0001), and the decrease in elastin content with ageing, no significant correlations 
were found between the elastin content and the Ca concentrations in the subjects 
studied (Elastin vs Ca: P = 0.575). Nevertheless, the negative interactions observed 
between Si and Ca and more strongly between Si and P suggest a protective effect 
for Si in preventing the calcification of the aortic wall (Figure 25 (b-c)).  The role of 
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silicon as calcium/phosphorus-antagonist has also been previously reported in a Si 
supplementation study in horses66. 
 Birchall has proposed that the essentiality of Si was not due to the direct action 
of the element on biological functions, but related to its ability to interact with other 
elements by limiting the bioavailability of aluminium and promoting copper 
utilization67. Minami and colleagues have investigated the Al and Si contents in the 
human aorta, reporting an age dependent accumulation of Al with a significant 
positive interaction with Si54. In the present study, an exponential increased in Al 
concentrations with age, but no correlation between Al and Si were observed. 
Although the number and age range of subjects are similar between both studies, 
differences in the methodology for trace element quantification may explain the 
variations between observations. 
 Although a small number of subjects were studied, a strong Cu and Si 
interaction (P = 0.01) was shown and implications of the silicon-facilitated copper 
utilization in promoting cardiovascular health have been pointed by several 
authors38, 39. Copper is an essential trace metal in humans, which is critical for 
connective tissue formation, iron metabolism, and free radical detoxification. The 
role of copper in connective tissue formation is largely recognized to its participation 
as a co-factor in the crosslinking of elastin and collagen by lysyl oxidase40, a copper-
containing enzyme. In other in vitro studies, Cu/Zn SOD activity was positively 
correlated with aortic stiffness and was suggested to play a crucial role in preventing 
atherosclerosis and maintaining the cardiovascular health30. Although in this study, 
no correlation was found between elastin and ageing, increased Cu/Zn SOD activity 
in aortic stiffness may explain the negative correlation between the copper content 
and the elastin burden observed in this study. 
 
 Elastin and collagen are the two main structural components of the aorta and 
major determinants of aortic health and mechanical properties. A biochemical assay 
was developed to measure collagen content, but due to operational problems, 
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collagen content in the aorta samples was not measured. Aorta mechanical testing, 
e.g. elasticity, was performed by Dr. Ian Wilkinson at Addenbrooke's Hospital. 
However the results were not shown in this thesis as the data was not available 
when writing this report. 
 
Other correlations with aortic health 
 The mean concentrations of the different elements were compared with the 
data collected from population studies and similarities were found between Al, Cu, 
Si, Zn, Ca, Mg and K levels (Table 6). The P and Fe concentrations were significantly 
lower in this study when compared with the referenced values in literature. 
Furthermore, a wide scatter distribution was also observed for the Fe concentration 
in the aortic wall. Fe contaminations from blood residues present in some samples 
are a possible explanation for this variation55. 
 The mean concentrations of the different elements differ between male and 
female subjects, with generally higher levels in female donors (Table 7). However, 
variations in the aortic wall mineral composition were mostly independent of the 
specimen gender, with the exception of Cu and Na levels. 
 The relationship between macro- and trace element concentrations in human 
tissues and the pathogenesis of cardiovascular disease have been investigated in 
many epidemiological studies68-70. In the present thesis and considering the amount 
of subjects, there was a surprisingly large number of correlations between elements, 
most of which have been reported previously. 
 Ca, P and Mg accumulation in senescence and their strong interaction in 
human aortas have been shown in several studies54, 71. Additionally the accumulation 
of Al was suggested to be associated with the increasing calcification of the ageing 
aortic wall, with Al being adsorbed on to the calcium phosphate mineral formed54, 72. 
Supporting these observations, strong correlations with ageing and between Ca, P, 
Mg and Al concentrations were also observed in this study. 
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 Among essential trace elements, Cu and Zn play a particular role in biological 
systems and are positively correlated in the aorta70. A disturbance of the trace 
elements balance in the human body creates possible risks of cardiovascular 
diseases. For example, the remodelling and homeostasis of the ECM is mediated 
primarily by a large group of zinc-dependent endopeptidases, the MMPs and their 
inhibitors73. Increased expressions of MMPs, such as MMP-2 and MMP-9 have been 
reported to be involved in the thinning and degradation of vascular elastin65. Even 
so, no correlations between the Zn content and age or between the zinc and elastin 
concentrations were found in this study. 
 Boron is a trace element playing an important role in mineral and hormonal 
metabolisms, cell membrane functions, and enzyme reactions74. Boron is thought to 
be implicated in the turnover of the ECM by modulating the production of MMP-2 
and MMP-975, which provides a plausible explanation for the significant and positive 
correlation between boron and zinc concentrations. 
 In the present study Fe was found to increase with senescence. Although iron is 
an essential element for many physiological processes, iron overload has been 
associated with increased cardiovascular risk. Excess iron can lead to tissue damage 
by promoting the generation of ROS, affecting the bioavailability of nitric oxide (NO) 
and thus impairing vasorelaxation76. ROS may also enhance the susceptibility of 
elastic fibres to subsequent elastase-mediate degradation, but the influence of 
oxidation on the structure and functions of elastic fibres is still poorly understood77.  
The homeostasis of sodium and potassium plays an important role in the blood 
vessel and general cardiovascular health. Sodium was found to have a strong 
negative correlation with potassium, and opposing associations between these 
elements and elastin concentration were identified (Figure 27 (b-c)). Supporting the 
current study findings, other investigators have demonstrated that excessive salt 
intake increased hypertension and that this effect is counteracted by potassium 
supplementation78. Additionally, in animal and cellular studies, Na and K were 
found to modulate elastin synthesis. In spontaneously hypertensive rats, 
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supplemented with NaCl, the aortic elastin was found to be slightly elevated when 
compared to the control79. Conversely, in chick VSMCs, high medium concentrations 
of potassium were found to decrease elastin synthesis80. 
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4.I.3 Conclusion 
 The circumstantial evidence supporting the conviction of silicon essentiality in 
the maintenance and preservation of the ECM health in animals is extensive. 
However, postulating a silicon requirement for humans is difficult because only 
limited data is available. If beneficial effects can be established, then silicon 
supplementation may play a major role in the vascular aging to promote health and 
longevity. 
 Aging effects and mutual correlations between the 12 elements analysed and 
the elastin burden in healthy human aortas were investigated. Many significant 
correlations and clear aging effects were found. It is worth emphasizing that despite 
the small number of samples, the results of the present study are mostly in 
agreement with the previous findings and reports in literature on minerals and 
aortic/cardiovascular health. 
 Earlier studies had suggested that the Si content in the aorta is higher than in 
other connective tissues, conversely low levels of silicon in human aortas were found 
in male and female subjects aged over 54 years compared to reported Si levels in 
other human arteries (e.g. radial artery). 
 Silicon levels did not appear to be markedly affected by either age or elastin 
content contrary to the strong literature evidence that Si affects ECM synthesis. 
Suggesting, that Si does not have a major effect on aortic health and maintenance of 
the ECM architecture once its formation is completed (elastin expression occurs only 
during late gestation until the end of childhood). 
 Results from the present study support the suggestion that silicon affects 
factors that are involved in progression of aortic stiffness, including the utilization of 
copper, essential in preventing oxidative damage to adult elastin fibres, and 
decreasing the adsorption of phosphorus to the matrix proteins involved in the 
calcification of the aortic wall. 
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4.II Method development for ‘combined’ elastin 
and collagen quantification 
4.II.1 Background 
 Elastin and collagen are the two main structural components of the aorta and 
major determinants of aortic health and mechanical properties25. 
 The matured cross-linked elastin produced during late fetal and early postnatal 
development is extremely stable and has a slow turnover rate with a longevity 
comparable to the human lifespan25. The aorta specimens analysed in this work were 
collected from human organ donors between the ages of 25 – 83 years, thus elastin in 
these samples will be grossly in form of mature/insoluble elastin. 
 In mature human aorta collagen type I and type III are the most abundant, but 
other isoforms of collagen are also present, e.g. collagen type IV, V and VIII25. 
Methods for the determination of collagen in tissue samples can be generally 
classified into two large groups. One group is based on immunochemical approach 
and the distinct chemical and physical properties of the different collagen types, 
where particular types of collagen can be individually analysed81; and the other 
comprises everything else, e.g. radiolabeling, chromatography and colorimetric 
assay, for the determination of total collagen content82.  
 In animal tissues, 4-hydroxyproline (OH-Pro) is a major component of collagen, 
comprising around 13.5% of the protein amino acid composition. The protein with 
the next highest OH-Pro content is elastin with 2%48. For this reason, the colorimetric 
OH-Pro assay is considered the gold standard and is customarily used to estimate 
the total collagen content with a reliable degree of accuracy48. However, even though 
the OH-Pro content in human elastin is only 2%, the elastin content in the aortic 
media is considerable higher than collagen, especially in younger specimens (< 50 
years old - Figure 27); imparting significance to elastin input in the total OH-Pro of 
the tissue lysate. Traditionally, collagen contents are estimated from the total OH-
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Pro concentration after subtraction of the elastin OH-Pro contribution, determined 
by the desmosine and isodesmosine content of the tested sample63. However, the 
processes for the accurate quantification of these two crosslinking amino acids 
(desmosine and isodesmosine) in elastic tissues are complex, expensive, and require 
more sample than the amount that is available83. 
 
Figure 27 - Relative (% [wt/wt]) and absolute (mg/cm) elastin and collagen concentrations of the human upper 
thoracic aortic media. Produced from Spina, 198363. 
 
 The aim of this developmental work was to devise a simplified method for the 
accurate measurement of the total collagen and elastin contents in human aortas 
using a single specimen for both assays. For this purpose, the immunoprecipitation 
assay principles were applied to isolate elastin from collagens to quantify total 
elastin and collagen contents. 
 Pig feet cartilage and chicken tendon were used to optimise the 
immunoprecipitation process and, elastin and collagen assays. 
4.II.2 Elastin and collagen extraction 
 Techniques for extraction and purification of mature elastin and collagen from 
connective tissues take advantage of the proteins unique and contrasting structural 
and chemical properties84. Two methods were investigated to extract elastin and 
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collagen from the test materials. These were the NaOH and oxalic acid extraction 
methods. 
4.II.2.1 NaOH treatment 
 Mecham85 and Daamen45 undertook a comparison of the most commonly used 
methods for purifying elastin. The results presented on the traditional hot alkali 
procedure showed that the final product still contained some non-elastinous 
material of microfibrillar nature, but the bright field microscopy revealed the 
absence of collagenous material45. 
 Elastin is insoluble when treated with 0.1M NaOH at 95⁰C, and collagen is 
solubilized in the supernatant fraction. The residue and collagenous fractions 
(supernatant) were analysed by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) and compared with the results obtained by Daamen 
and co-workers (Figure 28). Results indicated major protein contaminations in the 
elastin residue and high variability between samples. This procedure proved to be 
unreliable, time consuming and due to the viscous appearance of the insolubilized 
elastin above the supernatant, subject to elastin contaminations in the collagenous 
fraction during collection. 
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Figure 28 - SDS-PAGE electrophoresis of elastin preparations purified by hot alkali procedure. a) 
Representation of the reference lanes in Daamen et.al45 experiments. LMW: Lane marker weights (kDa). Lig 
nuchae: Horse ligamentum nuchae source of insoluble elastin. Procedure 1: Elastin treated with 0.1 M NaOH 
heated at 95⁰C for 45 min. b) Electrophoresis results of the supernatant and corresponding elastin residues 
fractions collected after treating three (1-3) samples of pig feet cartilage with 0.1M NaOH heated at 90⁰C for 45 
min. Note that only soluble contaminants (collagen and proteins) and/or elastin breakdown products will enter 
the gel. Insoluble elastin, which represent the vast majority of the residue, will not permeate the gel and will be 
visible at the top of the gel. 
4.II.2.2 Hot Oxalic Acid Treatment 
 Insoluble native collagen must be pre-treated before it can be converted into a 
form suitable for extraction, such as gelatine. Food and waste industries use weak 
acids, such as oxalic acid and acetic acid, to obtain gelatine from limed split wastes 
and fish skin51. Moreover oxalic acid treatment of elastic matrixes promotes the 
extraction and reduction of mature insoluble elastin to soluble fragments easily 
analysed by a colorimetric assay (Fastin™ Elastin assay, see Introduction section 
2.3.2.1). 
 The protocol for the extraction of elastin and collagen from the aortic tissue was 
optimized for the following parameters:  
I. Minimum sample weight required 
II. Wet or freeze dried sample 
III. Tissue homogenization technique 
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IV. Acid volume 
V. Number of extraction cycles 
VI. Extraction time 
VII. Storage of the extracts 
 Of all the methods investigated, elastin and collagen purification was more 
efficient if the tissues were dried and minced as fine as possible before the extraction 
steps (data not shown). Complete extraction of the elastin and collagen components 
of the elastic matrix was obtained with 3 cycles of heating the test homogenized 
samples in hot (95 - 100⁰C) oxalic acid (0.25 M) for one hour (Table 8). Insoluble 
elastin was extracted in the form of soluble cross-linked polypeptides elastin 
fragments (α-elastin), while collagen was partially hydrolysed to small peptides of 
molecular of various molecular weights. 
 The oxalic acid extracts (1st, 2nd and 3rd extractions) were pooled together 
(OAEp) for the separation of the elastin and collagen proteins (see below).  
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Table 8 - Elastin and collagen extraction. Descriptive analysis of the hot oxalic acid extractions and 
corresponding protein and elastin quantitative analysis performed on 3 samples of chicken tendon, with an 
average wet weight of 9.86 mg. Results are present as mean values of three samples. Elastin and protein content 
are expressed as μg in the volume of oxalic acid extract (OAE). 
 1st Extraction 2nd Extraction 3rd Extraction 4th Extraction 
Hot oxalic acid treatment     
Acid Volume (mL) 1.0 0.5 0.5 0.5 
Tissue Homogenization Yes No No No 
Temperature (⁰C) 102 98 100 100 
Time (min) 60 60 60 60 
Solid residue Yes Yes No No 
OAE     
pH 1-2 1-2 1-2 1-2 
Volume (mL) 0.97 0.47 0.49 0.51 
Elastin (μg) 177.30 27.70 2.04 0.0 
Total protein† (μg) 720.91 76.79 14.17 0.0 
†Total protein as determined by NIPA assay. Through this method elastin and gelatine protein 
amount recovery is 60-70% and 40-45%, respectively.  
4.II.3 Collagen and elastin separation 
  To accurately determine the absolute amount of collagen in the aortic ECM, 
an immunoprecipitation step was developed to remove the soluble elastin fragments 
present in the pooled extract solution obtained by the hot oxalic acid treatment 
(OAEp) (see above). By immobilizing the α-elastin fragments present in solution, all 
the collagens types, also solubilized during the acid extraction, are eluted 
collectively, allowing the total collagen quantification by OH-Pro without the 
interfering signal of the elastin’s OH-Pro. 
4.II.3.1 Elastin Immunoprecipitation 
 The Thermo Scientific Pierce Classic IP kit was preferred to perform the 
immunoprecipitation of the elastin fragments obtained after the hot oxalic acid 
extraction. The kit uses high-capacity Protein A/G agarose affinity resin and a 
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microcentrifuge spin column format that helps to ensure effective washing and 
separation of samples from the beaded agarose resin.  
 The mouse monoclonal anti-elastin antibody [10B8] from Abcam, Cambridge, 
UK was selected for the immobilization of α-elastin according to the following 
criteria: 
I. Specificity for elastin and elastin peptides. 
II. Tested successfully for IP applications. 
III. Species reactivity, i.e. human reactivity. 
IV. Isotype with strong binding affinity for Protein A/G. 
V. Monoclonal antibody. 
a. Compared to polyclonal antibodies, monoclonal antibodies have 
less batch variability, e.g. the results from monoclonal antibodies 
are highly reproducible between experiments.  
b. Its specificity makes monoclonal antibodies extremely efficient 
for binding antigens within a mixture of related molecules and 
less likely to cross-react. 
 The immunoprecipitation procedure was developed based on the protocol and 
reagents provided within the Thermo Scientific Pierce Classic IP kit. The conditions 
for the immobilization of the elastin fragments solubilized in the acid extracts were 
optimized by examining the effect of various critical parameters such as extract pre-
clearing, minimum antibody and maximum protein loading, order of assembly of 
the immobilized antibody/antigen complex and buffers compositions and 
interference with the quantitative assays (hydroxyproline and Fastin™ Elastin 
assays) (Table 9).  
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Table 9 - Optimal conditions for IP assay.  
 Optimal Conditions 
Order of assembly Beads – Antibody – Antigen 
Antibody  [10B8] 
Volume (μL) 7 
Sample  
pH 7-8 
Pre-clearing Yes 
Volume (μL) 250 
Total protein† (μg) 30-50 
Wash buffer interference ‡  
Lysis/Wash Buffer Yes 
TBS wash Buffer (1x) No 
† As determined by NIPA assay. 
‡ Buffer interference with control assay: Fastin Elastin Assay. 
 Antigen yield was highest when first binding 7 μg of antibody to 30 μL of 
Protein A/G beaded support, followed by the incubation of the immobilized 
antibody with the 250 μL of the previously pre-cleared and neutralized tissue extract 
(Table 9). Sample pre-clearing is an optional step designed to remove proteins and 
ligands that bind non-specifically to the beaded support. This involves adjusting the 
pH of the sample (oxalic acid extracts) to neutral pH (pH 7-8).  IP Lysis/Wash buffer 
provided with the IP kit was found to interfere with the Fastin™ Elastin assay. 
Moreover collagen elution was more effective when using the wash detergent-free 
1xTBS buffer. 
   
 A representative scheme of the final elastin immunoprecipitation protocol is 
displayed in Figure 29 and the protein and elastin quantitative analysis of the 
different fractions collected with the IP assay are summarize in the Table 10. 
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Figure 29 - Immunoprecipitation assay procedure. a) Sample pre-clearing step to reduce non-specific binding of 
protein to the agarose beads: adjust the pH of sample to 7-8. b) Formation of the antibody – beads complex: 
incubation for 5h at 4⁰C of the Pierce protein A/G agarose beads with the monoclonal antibody. Centrifuge and 
discard supernatant. c) Formation of the immune complex: incubation for 15 -17h at 4⁰C of the antibody – beads 
complex with the pre-cleared solution. d) Collected collagen fractions: centrifuge and collect the unbound 
collagenous fraction. Wash the spin column and collect the eluate solution, twice. e) Collect elastin fractions: 
incubate for 10 min at 97⁰C, the immune complex with the Pierce elution buffer. Centrifuge and collect the elastin 
fraction. Repeat the incubation with the elution buffer twice. 
 Prior to the IP assay, the various OAEs collected were pooled together (OAEp), 
analysed for elastin and protein content with the Fastin™ Elastin assay and NIPA 
assays, respectively, and a suitable sample volume (≈100 μL) was calculated for the 
adequate protein loading concentration into the immunoprecipitation assay (optimal 
concentration of 30 – 50 μg) (Table 10). The sample was further diluted to a total 
volume of 250 μL with 1xTBS buffer and the IP assay carried out as previously 
described (Figure 29). The multiple collagen and elastin fractions collected were 
analysed for elastin and total protein content by Fastin™ Elastin assay and NIPA 
assay, respectively (Table 10). 
 The results from Table 10, suggested a high affinity of the antibody for the 
elastin protein, as less than 1 μg of elastin was detected in the collagenous fractions. 
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Differences between the calculated elastin concentration loaded in the column (7.2 – 
13.6 μg) and the total elastin recovered (5.3 – 12.2 μg) are probably related to 
instrumental errors (pipetting and tube transferences). 
Table 10 - Elastin and total protein analysis of the collagen and elastin fractions collected from the IP assay 
developed. IP assay performed on OAE obtained from chicken tendon, n=3 samples/specimens.  
 Elastin (μg) Total Protein† (μg) 
OAEp (100 μL) 7.2 – 13.6 42.6 – 50.1 
Collagen  Fraction   
1st eluate < 1.0 20.2 – 23.6 
2nd eluate 0.0 7.4 – 9.0 
3rd eluate 0.0 < 1.8 
Elastin fraction   
1st eluate 4.3 – 6.0 NP 
2nd eluate < 4.3 NP 
3rd eluate 0.0 NP 
Recovery (%) 70 - 80 ~65‡ 
†As determined by NIPA assay. Through this method elastin and gelatine 
protein amount recovery is 60-70% and 40-45%, respectively.   
‡Total protein recovery will always be lower than 100% as the elastin should be 
collected in the immobilized fraction 
NP: assay not performed 
4.II.4 Collagen assay 
 The collagenous fractions collected in the immunoprecipitation assay (Table 10: 
collagen fraction = 1st and 2nd eluate), where pooled together for further collagen 
analysis by the hydroxyproline assay. The pooled samples were freeze dried for 48 h 
to concentrate the protein amount. 
 The OH-Pro assay procedure was based on the vapour-phase HCl microwave 
hydrolysis of the freeze dried residue and subsequent determination of the free 
hydroxyproline in the hydrolysed sample. Chloramine-T was used to oxidize the 
free hydroxyproline for the production of a pyrrole, and the addition of Ehrlich's 
reagent resulted in the formation of a chromophore that can be measured at 540 nm. 
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 As 4-hydroxyproline (OH-Pro) is a major component of collagen that 
comprising around 13.5% of the protein amino acid composition, the total collagen 
content of the tissue lysate is determined assuming that this protein contains an 
average of 13.5% w/w of OH-Pro residues48. 
 
 A complete protocol of the developed assay for the determination of collagen 
and elastin contents can be found in Appendix D. 
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4.II.5 Conclusion 
 This project was successful in establishing a new biochemical method that 
allows the analysis and quantification of elastin and collagen using one single 
specimen. This allowed a significant reduction in the amount of sampled used while 
still obtaining accurate data on the elastin and collagen contents of the human aorta, 
using cost effective techniques. Disadvantages to the new protocol include its 
susceptibility to experimental errors due to the usage of low volumes and sample 
loss due to material transference between the various tubes. Measures can be 
adopted to reduce these problems such as careful homogenization of the sample 
solutions before handling and the recording of the weights of the sample volumes 
used in the assays. 
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5 Future Research 
 Silicon is the third most abundant trace-element in the human body. 
Considering the abundance of silicon, both in the nature and in humans, it is 
expected that it should play an important role in human and animal health. The Si 
potential involvement in atherosclerosis has been suggested by several authors. 
However, when the role of trace elements in various diseases is discussed, it is not 
only essential to know the concentrations of these elements in tissues under disease, 
but also in normal conditions, which has not received adequate attention. Additional 
insights into the Si biological mechanisms of action and its role in cardiovascular 
health, along with larger studies on both animals and humans are required. 
 In this study, due to instrumental problems and time constrictions, collagen 
was not determined and association between Si and collagen and aortic 
performance, e.g. elasticity, may provide crucial information and must be 
investigated, this being a subject for future complementary studies. 
 Whether Si has a biological role in man is not known, but large evidence from 
animal and in vitro studies have continuously suggested that Si contributes to the 
synthesis and architecture of the ECM matrix proteins, and is uniquely localized in 
active growth areas in young bones of animals86. Human studies have also implied a 
higher requirement of Si in newborns and developing foetus, serum Si levels where 
found higher in infants compared to older children and adults49, 87. Knowing that 
elastin expression occurs over a narrow window of development, beginning in mid-
gestation and continuing at high levels through the postnatal period with minimal 
synthesis in the adult life25, a question stands up: could the essential role of Si in the 
maintenance of the resilience and architecture of the aortic ECM matrix be connected 
to its early development? Could the Si levels in foetus and young children aorta be 
correlated with longevity and lower cardiovascular incidence? From this viewpoint, 
supplementation of the regular diet with bioavailable form of silicon in pregnant 
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women may, therefore, have a long-term therapeutic potential including prevention 
of degenerative processes. Further research is needed to determine the role of silicon 
in the developing foetus and long-term outcomes. 
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Appendix A : Elements of lesions areas in the 
human aorta 
A.1 Background 
 To elucidate the mineral and structural composition of the ageing human aorta, 
this thesis investigated age- and gender-related changes of minerals and elastin in 
aortas from male and female organ donors. It was established that the accumulation 
of calcium, phosphorus and aluminium occurs with advancing age. Relationships 
among the element concentrations were investigated and significant direct 
correlations were found between calcium, phosphorus, magnesium and aluminium 
levels. In contrast, inverse correlations were found between silicon and phosphorus 
contents, suggesting a possible preventive role for silicon in the maintenance of 
aortic health. However, mechanisms are not clear. 
 During the sampling of the aortas, three specimens were identified as being 
abnormal. Increased aortic wall thickness was observed in one sample and, visible 
calcified areas in two others (Results - Figure I.1). For easier identification, the first 
sample is classified as stiff aorta, and the latter as calcified aortas. 
 In the present Appendix, the mineral concentrations and the elastin contents in 
the lesion and lesion-surrounding sites of the stiff and calcified aortas were 
investigated and compared with the average results from the normal aortas. 
A.2 Results and Discussion 
 Abnormal aortas were identified in three subjects; all were male, and the ages 
were as follow: stiff aorta = 70 year old male and calcified aortas = 55 and 70 years 
old males. Due to the limited number of samples (n=3), no statistical analysis was 
performed in the data presented below.  
 Table A.1 and A.2 show the mineral and elastin content, respectively, of the 
stiff and calcified aortas in the lesion and surrounding area, separately, and 
compared with the control aortas (normal). No manganese or boron was detected 
A.2 
 
when analysing both the lesion and the surrounding sites of the abnormal aortas by 
ICP-OES. 
Table A.1 - Content of elements in the stiff and calcified lesions and surrounding lesion free areas of the 
abnormal aorta samples, and mean concentrations in normal aorta samples. Values expressed as mg/g dry 
weight for the elements: Ca, P, Mg, Na and K; and expressed as μg/g dry weight for the elements: Al, Cu, Si, Fe 
and Zn. 
 Stiff (n=1)  Calcified (n=2)  Normal (n=40) 
 Lesion Surrounding  Lesion Surrounding  Mean ± SD 
Ca 2.21 9.89  142.20 8.70  9.3 ± 3.0 
P 1.29 4.05  34.80 3.93  3.4 ± 1.3 
Mg 0.14 0.89  1.21 0.55  0.9 ± 0.4 
Na 2.78 6.13  3.10 2.38  6.2 ± 4.4 
K 4.00 7.50  6.36 9.24  7.1 ± 5.1 
Al 1.78 9.35  87.28 9.18  8.3 ± 3.0 
Cu 1.20 5.22  1.68 1.71  4.1 ± 2.2 
Si ND ND  5.87 18.89  14.1 ± 11.7 
Fe 8.58 26.15  71.09 43.55  45.7 ± 27.9 
Zn 22.94 79.51  75.44 41.52  70.9 ± 19.4 
ND – not detected 
Table A.2 - Content of the elastin concentrations in the stiff and calcified lesions and surrounding lesion free 
areas of the abnormal aorta samples, and mean concentrations in normal aorta samples. Values expressed as 
mg/g dry weight. 
 Stiff (n=1)  Calcified (n=2)  Normal (n=40) 
 Lesion Surrounding  Lesion Surrounding  Mean ± SD 
Elastin 120.38 316.38  74.66 101.24  225.1 ± 62.8 
A.2.1Stiff aorta 
 The element contents of the stiff lesion were much lower than in its 
surrounding areas, but the values were still within the range previously established 
for the control aortas (Table A.1). The elastin content of the stiff area (lesion) was 
only slightly below the previously defined range for normal aortas, but when 
comparing the elastin levels between the lesion and the lesion-surrounding sites, a 
decrease in almost 3-folds was observed (Table A.2).  
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A.2.2 Calcified aorta 
 Tables A.1 and A.2 show the content of the calcified aortas in the lesion and 
surrounding area plus the mean concentrations of control aortas (n = 40).  Elemental 
concentrations in the calcified and surrounding areas determined in this study were 
found to be very similar to a published reported by Tohno and colleagues2, where 
the authors investigated the concentrations of some elements (Ca, P, S, Mg, Fe, Zn, 
Pb and Al) in calcified and calcification surrounding sites of the thoracic aorta. 
 Generally, higher element concentrations were found for the calcified lesions 
when compared with the surrounding sites where the results were similar to the 
control samples. As expected, the contents of calcium, phosphorus and aluminium 
are extremely high in the calcified areas, compared with the surrounding and control 
samples. However, magnesium, sodium, potassium and copper contents did not 
seem to be largely altered by the calcification of the aorta. Interestingly, in calcified 
sites, Si content was approximately 4- and 3-times lower than in surrounding sites 
and mean content in normal aortas, respectively; endorsing the previous observation 
in this thesis than Si may have a role in aorta calcification. 
 Elastin content in the calcified and surrounding sites was identical (Calcified: 
74.66 ± 28.2 mg/g & Surrounding: 101.24 ± 86.1 mg/g), but approximately half of the 
amount found in the control samples. In fact, Bobryshev et. al3 examined the 
association of calcified deposits with ECM components, such as elastin, and 
observed that calcification requires a pre-existing structural base such as altered 
elastin fibres and that the co-localization of calcified deposits and elastin fibres was 
followed by destruction of the elastin.  
A.3 Conclusion 
 Data from the elemental and structural composition of the stiff, non-calcified 
sample were in agreement with literature studies proposing that the macroscopic 
increase in wall thickness observed in the ageing arteries is associated with increased 
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collagen expression as a repair mechanism for the degeneration in the elastin fibres1 
(hypothesis not study in this project). 
 Vascular stiffening is a universal change associated with advancing age and 
develops from a complex interaction between structural and cellular elements of the 
vessel wall. These vascular alterations are influenced by the mineral status of the 
organism. Stiffness does not seem to occur uniformly along the aortic wall, which is 
evidenced by the clear differences between the elemental concentration in the lesion 
sites and the surrounding areas. Moreover, the elemental analysis indicated a very 
different and characteristic mineral profile between abnormal aortas dependent on 
the presence of calcified deposits in the arterial wall.  
 The data shown in this Appendix support the findings in the main thesis for a 
Si preventive role in ECM calcification. 
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Appendix B : Elements age and gender correlations 
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Figure B.1 - Gender distribution of Zn and Fe (left Y axis) and, B, Mn and Al (right Y axis) in the human aorta 
samples. Data is shown as box-plots, where the horizontal lines indicate 10th, 25th, 50th (or median), 75th and 
90th percentiles; the plus signal shows the mean, n represents the number of subjects (female and male) in this 
study. 
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Figure B.2 - Gender distribution of Ca, P and K (left Y axis) and, Mg (right Y axis) in the human aorta samples. 
Data is shown as box-plots, where the horizontal lines indicate 10th, 25th, 50th (or median), 75th and 90th 
percentiles; the plus signal shows the mean, n represents the number of subjects (female and male) in this study. 
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Figure B.3 - Changes in B (a), Mn (b), Mg (c) and K (d) concentrations in the aorta. Concentrations are 
represented for each subject and the dashed lines show the correlations with age. The thin horizontal dotted line 
shows the mean concentration for the element. Outliers are highlighted in red and were not included when 
carrying out the correlations. Spearman’s correlation coefficients (r2) and P-value are shown. Note: removing the 
value at 25 years did not affect the correlation shown. 
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Appendix C : Elements, elastin and BMI correlations 
Table C.1 - Correlations between element concentrations, elastin concentrations and BMI in the human aorta samples. Spearman’s correlation coefficient (r2), corresponding P-
value. 
 Si Zn B Mn Cu Fe Al Mg Ca P Na K Elastin BMI 
Si               
P-value               
Zn 0.211              
P-value 0.223              
B 0.495 0.579             
P-value 0.019 0.003             
Mn 0.288 0.211 0.471            
P-value 0.279 0.417 0.066            
Cu 0.438 0.523 0.805 0.542           
P-value 0.010 0.001 < 0.0001 0.025           
Fe 0.154 -0.103 0.270 -0.203 -0.131          
P-value 0.385 0.534 0.213 0.451 0.435          
Al 0.228 0.270 0.086 ND 0.321 0.369         
P-value 0.379 0.236 0.919 ND 0.156 0.100         
Mg -0.108 0.279 0.298 0.109 0.378 -0.149 0.682        
P-value 0.536 0.086 0.167 0.688 0.019 0.372 0.001        
Ca -0.202 0.226 0.217 -0.203 0.378 -0.003 0.805 0.650       
P-value 0.245 0.161 0.308 0.434 0.018 0.985 <0.0001 <0.0001       
P -0.322 0.106 -0.071 -0.297 0.096 -0.019 0.882 0.694 0.895      
P-value 0.059 0.514 0.741 0.248 0.560 0.907 <0.0001 <0.0001 <0.0001      
Na -0.067 0.089 -0.886 ND 0.283 -0.002 -0.197 -0.456 0.162 -0.089     
P-value 0.791 0.695 0.033 ND 0.202 0.994 0.391 0.033 0.471 0.695     
K -0.049 0.351 0.486 ND 0.003 -0.039 0.204 0.418 -0.107 0.128 -0.755    
P-value 0.848 0.110 0.356 ND 0.990 0.863 0.375 0.053 0.636 0.570 <0.0001    
Elastin -0.322 -0.083 -0.401 -0.041 -0.041 -0.006 -0.256 -0.229 0.094 -0.010 0.574 -0.532   
P-value 0.064 0.620 0.064 0.909 0.812 0.970 0.263 0.167 0.575 0.952 0.005 0.011   
BMI -0.264 0.062 -0.342 -0.073 -0.064 -0.064 0.119 -0.080 0.150 0.067 0.063 -0.112 0.207  
P-value 0.132 0.709 0.110 0.948 0.664 0.703 0.606 0.633 0.361 0.684 0.782 0.619 0.219  
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Table C.2 - Correlations with Cu and Na concentrations in female and male human aorta samples. Spearman’s correlation coefficient (r2), corresponding P-value are shown 
 Cu 
Females 
Cu 
Males 
 Na 
Females 
Na 
Males 
Si 0.603 0.298  0.036 0.118 
P-value 0.013 0.229  0.963 0.735 
Zn 0.472 0.514  -0.190 0.121 
P-value 0.048 0.017  0.665 0.681 
B 0.692 0.830  ND ND 
P-value 0.009 0.005  ND ND 
Mn -0.333 0.952  ND ND 
P-value 0.385 0.001  ND ND 
Cu    -0.024 0.385 
P-value    0.977 0.175 
Fe -0.005 -0.313  -0.095 0.191 
P-value 0.985 0.167  0.840 0.513 
Al 0.786 0.165  -0.452 0.027 
P-value 0.028 0.590  0.267 0.929 
Mg 0.566 0.312  -0.476 -0.367 
P-value 0.018 0.169  0.243 0.197 
Ca 0.265 0.412  -0.357 0.253 
P-value 0.287 0.064  0.389 0.383 
P -0.024 0.286  -0.524 0.099 
P-value 0.926 0.209  0.197 0.737 
Na -0.024 0.385    
P-value 0.977 0.175    
K 0.643 -0.130  -0.476 -0.692 
P-value 0.096 0.659  0.243 0.006 
Elastin -0.615 0.455  0.429 0.464 
P-value 0.009 0.038  0.299 0.095 
BMI 0.488 0.231  0.381 0.143 
P-value 0.047 0.313  0.360 0.626 
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Appendix D : Elastin and collagen assay 
D.1 Protocol for the Pierce Classic IP Kit 
A.  Tissue Lysis 
1. Cut the tissue in ~10 mg pieces and freeze dry it. 
2. Add 400 µL of 0.25M oxalic acid to the tissue and homogenize with an electric homogenizer, 
speed 4 for 1 min. 
3. Rinse the blade with 600 µL of 0.25M oxalic acid. 
(Further extractions with 500 µL of 0.25M oxalic acid) 
4. Incubate for 1 hour at 90⁰C with plate agitation. 
5. Centrifuge at ~11 000 rpm for 20 minutes to pellet the cell debris (centrifuge 5804R G03). 
6. Carefully transfer the supernatant to a new tube for further analysis: 
a. Elastin quantification:  
50 µL of supernatant → Fastin Elastin Assay 
b. Protein quantification: 
50 µL of supernatant →NIPA assay 
(The amount of total protein per IP reaction is 30–50 μg)  
c. Immunoprecipitation assay (OSAp): 
100 µL of supernatant + 52 µL NaOH 1M (freshly prepared) + 250 µL of 1x TBS Buffer 
pH: 7-8 (If further dilutions are necessary use 1x TBS buffer) 
B.  Pre-clear lysate using the Control Agarose Resin 
1. Add 80 μL of the Control Agarose Resin slurry into a spin column. 
2. Centrifuge column to remove storage buffer. 
3. Add 100 μL of clearing solution to the column, centrifuge and discard the flow-through.  
4. Add 300 μL of OSAp to the column containing the resin and incubate at 4ºC for 1 hour with gentle 
end-over-end mixing. 
5. Centrifuge column at 4 000 rpm for 1 minute. Discard the column containing the resin and save 
the flow-through, which will be added to the immobilized antibody. 
C.  Capture of the antibody in the resin  
1. Gently swirl the bottle of Pierce Protein A/G Agarose to obtain an even suspension. Using a cut 
pipette tip, add 30 μL of the resin slurry into a column. 
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2. Place column into a microcentrifuge tube and centrifuge at 4 000 rpm for 1 minute. Discard the 
flow-through.  
3. Wash resin twice with 100 μL of cold 1x TBS Buffer. Discard the flow-through after each wash. 
4. Gently tap the bottom of the spin column on a paper towel to remove excess liquid and insert the 
bottom plug. 
5. Add 7 μL of antibody *10B8+ to the spin column, plus 150 μL of 1x TBS Buffer. Attach the screw 
cap and incubate for 5 hours at 4⁰C with gentle end-over-end mixing. 
6. Loosen the screw cap, remove bottom plug and place the column in a collection tube. Centrifuge 
column and save the flow-through. (Antibody fraction) 
7. Wash resin twice with 200μL of cold 1x TBS Buffer. Discard the flow-through after each wash. 
D.  Preparation of the Immune Complex 
1. Add 250 μL of the pre-cleared solution (see section B.) to the spin column. 
2. Incubate overnight (15-17 hours) at 4⁰C with gentle end-over-end mixing. 
---------------- 
3. Loosen the screw cap, remove bottom plug and place the column in a collection tube. Centrifuge 
column and save the flow-through. (Collagen + Proteins) 
4. Add 200 μL of 1x TBS Buffer and centrifuge and save the flow-through. (Collagen + Proteins 2) 
5. Wash the resin three times with 200 μL 1x TBS Buffer and centrifuge after each wash. Discard the 
flow-through after each wash. 
6. Wash the resin once with 100 μL of 1X Conditioning Buffer. Centrifuge. 
E.  Elution of the Immune Complex 
Low-pH elution:  
1. Place the spin column into a new collection tube and add 100μL of Elution Buffer.  
2. Cap the column and incubate for 10 minutes at 70⁰C with gentle mixing. 
3. Centrifuge the tube and collect the flow-through. (Elastin) 
4. Perform 2 additional elutions. 
5. Analyse each eluate separately to ensure that the antigen has completely eluted.  
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D.2 Protocol for the Hydroxyproline Collagen Determination 
A. Preparation of the Reagents 
1. HYP Stock Solution 
a. In 25 mL of 1 mM HCl add: 
i. HYP: 0.130g 
b. Store in 1mL aliquots at -20⁰C 
2. Buffer Solution 
a. In 10 mL of UHP water add: 
i. Sodium Acetate: 0.574g 
ii. Trisodium Citrate: 0.588g 
iii. Citric Acid: 0.0945g 
b. Adjust pH to 6,0. 
c. On the day of the assay: 
i. Dilute 3 mL of Isopropanol 50% in 2mL of buffer solution 
3. Oxidant Solution 
a. On the day of the assay, in 1mL of buffer add: 
i. Chloramine T: 0.085g 
4. Erlich’s Reagent 
a. In 6 mL of perchloric acid 70% add: 
i. pDABA: 4.03g 
(this solution cannot be older than 4 days) 
b. On the day of the assay: 
i. Dilute 1 mL of pDABA in 3 mL of Isopropanol 50% 
B. Freeze Drying 
1. Pool together the collagenous fractions collected in the immunoprecipitation assay. 
2. Transfer and freeze dry overnight in the glass vials of the microwave (MW) system. 
C. Microwave Vapour Digestion 
1. Prepare 10 mL of 6 M HCl and add it to the container of the MW system. 
2. Place the samples in the container and leave it at -80⁰C for 30 min. 
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a. MW digestion parameters - Temp: 150⁰C; Power: 150 W; Time: 15 min. 
D. Sample Reconstitution 
1. Transfer the sample to an eppendorf tube by carefully adding a total volume of 200 
μL of 50%isopropanol and pipetting the suspended residue. 
2. Vortex until dissolution, and spin down the solution using a centrifuge. 
E. Hydroxyproline Standards 
Table D.1 – Hydroxyproline standards preparation and final amino acid (OH-Pro) concentration.  
 HYP stock (μL) Isopropanol 50% (μL) 
Concentration 
(mg/mL) 
C0 0 500.00 0 
C1 3.85 496.15 0.04 
C2 11.54 488.46 0.12 
C3 23.08 476.92 0.24 
C4 18.46 461.54 0.40 
C5 48.08 451.92 0.50 
F. Hydroxyproline Assay 
1. In a 96 well-plate add: 
a. 10 μL of sample/standard solution 
b. 30 μL of buffer solution 
c. 10 μL of oxidant solution 
2. Shake and leave at room temperature for 5 min. 
3. Add 0.1 mL of Erlich’s reagent. 
4. Shake and incubate for 30 min at 60⁰C. 
5. Cool to RT for 10 min. 
6. Read OD at 540 nm. 
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Appendix E : Silicon levels in the human skin 
E.1 Background 
 Skin is the most extended and heaviest organ of the human body, acting as a 
barrier between the internal and external environment. Nutrition is one the most 
important factors that is involved in modulating skin health, and several studies 
have attempted to improve skin health by changing or manipulating the diet1. 
 Human skin ageing is accompanied by many clinical signs, the most evident 
of which are dryness, colour changes, wrinkles and loss of firmness. These clinical 
manifestations reflect morphological and structural changes in the skin that can be 
broadly categorized as either photoageing or intrinsic ageing2. The first is the 
result of UV exposure. The second is similar to that occurring in most internal 
organs, including the aorta, and is clinically associated with irreversible tissue 
degeneration, with a marked decrease in collagen, glycosaminoglycans and 
proteoglycans, and elastin fibres degeneration3. 
 High levels of silicon were found in rat connective tissues such as bone, aorta 
and skin4. Even though numerous observational studies have suggested the 
beneficial effects of silicon on skin health, no concrete evidence exists of the silicon 
mechanism of action of silicon in skin. Human supplementation studies, for 
example, have reported that when Si was administered orally a positive effect was 
observed in the skin surface and mechanical properties with significant 
improvement in the thickness and turgor of the skin and wrinkles5, 6. 
 The only study investigating the silicon content of human skin dates back to 
1927 and used gravimetric and colorimetric assays to determine the Si content. 
Brown and colleagues reported that silicon concentrations varied between 7.5 – 9.0 
mg/g dry weight with a positive, although not significant, trend to decrease with 
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ageing7. However, the age of the study and the quantification method raises 
concerns about the validity of the values reported. 
 In this Appendix, the analytical results from a pilot study in human punch 
skin biopsies (VMS samples), obtained from and in collaboration with Dr Ian 
Wilkinson, are presented. Skin tissue bank samples (TB samples) were also 
obtained to evaluate possible ionic contaminations during skin sample collection 
and to assess the validity of the analytical method. 
 The main aim of this pilot study was to establish the changes in silicon levels 
in human skin with ageing and between genders. 
 Sample preparation and analytical methodologies were developed and 
optimized by Dr. Sylvaine Bruggraber in the BMR group at MRC-HNR, 
Cambridge, UK. At the same institution, samples were analysed for sodium, 
potassium, calcium and silicon content by ICP-OES by Miss Julia Schmidt and 
myself separately. 
E.2 Methodology 
E.2.1 Sample acquisition 
 Human skin biopsies and skin tissue bank samples were provided by Dr Ian 
Wilkinson and Dr Viknesh Selvarajah from Addenbrooks’ Hospital, Cambridge, 
UK. VMS skin biopsies were approximately 4-5 mm deep and sampled both the 
epidermis and dermis. They were collected from the lower back under local 
anaesthesia. 
E.2.2 Elemental Analysis 
 The skin element concentrations of Na, K, Ca and Si were determined via 
ICP-OES (Jobin Yvon Horiba – ULTIMA 2000-2).  
 For element determination, samples were digested according to the 
following procedure: the skin samples were freeze dried overnight (Mini Lyotrap, 
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LTE scientific, Ldt, Greenfield, Oldham, UK) until constant weight. The dried 
material was accurately weighted to determine water content loss and then 
digested with 1:1 (v/v) mixture of high purity (69%) HNO3 and high purity (40%) 
H2O2. The samples were incubated overnight at room temperature followed by a 
second incubation overnight in a water bath at 40⁰C. All samples were digested to 
completeness and diluted with 450 μL of a sample diluent consisting of 1% HNO3 
and 200 ppb strontium (Sr) as an internal standard. For the Na and K analysis and 
aliquot (100 μL) of previously digested and diluted samples were further diluted 
with water to a final volume of 1000 μL.  
 Sample blanks for control of the digestion process were prepared in a similar 
manner and analysed collectively with the samples. Two sets of multi-element 
standards (Na/K and Ca/Si) were prepared from 1,000 ppm aqueous stock 
solutions, with final concentrations per element ranging from 0 to 10 ppm in a 
diluent matched to the digested solution (9% (v/v) HNO3 for Ca/Si standards; and 
1.7% (v/v) HNO3 for Na/K standards). 
 Peak profiles were used and the elements were measured at: 588.995 nm for 
Na, 766.490 nm for K, 393.366 nm for Ca, 251.611 nm for Si and 346.446 nm for Sr. 
The running conditions for the digested skin samples by ICP-OES are summarized 
in Table E.1. 
Table E.1 - Running conditions of ICP-OES for the analysis of skin samples. 
 
Analytical Conditions Na/K Ca/Si 
RF power (W) 1000 1000 
Plasma gas (L min-1) 12 10 
Sheath gas (L min-1) 2 2 
Auxiliary gas (L min-1) 0.0 0.0 
Speed pump (rates min-1) 8 8 
Nebulisation flow rate (L min-1) 0.02 0.02 
Plasma stabilization time (s) 10 10 
Number of replicates 3 3 
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Matrix effects were corrected using pooled sample-based standards (PSBS). 
Briefly, after elemental analysis by ICP-OES the remainder of the digested samples 
were pooled into two new tubes, one for Na/K analysis and the other for Ca/K 
analysis. Aliquots of the pooled samples were spiked with different concentrations 
(0 – 10 ppm) of the standard solutions, previously prepared for ICP-OES analysis. 
The TB samples were digested and analysed by a similar procedure 
described above for the VMS samples. The TB samples were larger than the VMS 
samples, therefore the volumes of acid (HNO3 + H2O2) and diluents were adjusted 
accordingly to the difference in weights. 
Element concentration was measured in mg or μg of dry sample mass and 
corrected for matrix effect. The limits of quantification for the samples were 
restricted by the background levels of the elements analysed in the sample blanks 
of each batch:                           . 
E.3 Results 
 The demographic distribution of the punch skin biopsies (VMS) and the skin 
tissue bank (TB) samples analysed are described in Table E.2. Skin TB samples 
were collected from patients undergoing breast surgery and only female subjects 
were available.  
Table E.2 - Subjects demographic data of the samples analysed in this study. 
 VMS TB 
N 47 17 
Gender   
Male 24 0 
Female 23 17 
Age   
Mean 43 43 
Range 19 – 68 19 – 72 
A.18 
 
E.3.3 VMS vs TB 
 A total of 47 VMS and 17 TB skin samples were collected and analysed with 
an average dry weight of 8.5 ± 4.6 mg and 22.6 ± 10.6 mg, respectively. Na, K, Ca 
and Si concentrations (males and females) are shown in Table E.3 separately for 
the VMS and TB samples. When comparing the VMS and TB samples, VMS Ca 
and Si concentrations were significantly lower than TB samples. 
 In some VMS samples the Ca (n = 8) and Si (n = 6) contents were below the 
detection limit and thus the elements concentration was not determined. 
Moreover a Si contamination in one batch of the VMS samples was identified, and 
the results for this set of samples (n = 12) was not included here. 
Table E.3 - VMS and TB skin samples concentrations of Na, K , Ca and Si. Mean values ± SD, range and 
total number of subjects. 
 VMS‡  TB‽ 
 Mean ± SD Range n  Mean ± SD Range n 
Na (mg/g) 7.10 ± 2.36 1.46 – 11.85 47  8.54 ± 2.35 5.46 – 13.74 17 
K (mg/g) 2.55 ± 0.88 1.23 – 4.77 47  2.00 ± 0.62 0.93 – 3.49 17 
Ca (mg/g)      0.32 ± 0.06 †* 0.18 – 0.49 40  0.70 ± 0.24 0.38 – 1.12 17 
Si (μg/g)     9.67 ± 8.31 †** 1.57 – 36.15 30  16.13 ± 7.69 7.09 – 30.53 17 
†Mean VMS vs TB: *P = 0.002; **P < 0.0001 (Mann-Whitney t test). 
‡Female + male donors/cohort. 
‽Female donors/cohort 
E.3.4 Age and gender variations 
 The elemental distribution per gram dry weight of tissue of the VMS skin 
samples as a function of age and gender were plotted in Figure E.1. Excluding 
silicon, similar behaviours were observed in the elements content between ageing 
males and females; sodium and potassium concentrations decreased and calcium 
concentration increased with ageing. Conversely, silicon levels appear to decrease 
in ageing males and increase in ageing females. No significant impact of age was 
found in the female and male element concentrations with the exception of Si in 
females (r = 0.736 and P = 0.01). 
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Figure E.1 - Age-related changes in Si (a), Na (b), K (c) and Ca (d) contents in VMS skin samplesfrom male 
and female donors. Concentrations are presented for each subject and the dashed lines show the best fit line 
through the data points (male and female) separately .The thin horizontal dotted line shows the mean element 
concentration (male and female). Outliers are highlighted in red and were not included when carrying out the 
correlation between the element content, ageing and gender (Spearman’s correlation).  
 Overall, the mean element concentrations in male VMS skin samples were 
higher than in females. However, only for Na, K and Si where these differences 
statistically significant, P = 0.03 for Na; P = 0.0007 for K and P = 0.02 for Si (Figure 
E.2). 
A.21 
 
S
i 
(
g
/g
 d
ry
 w
g
t)
Female Male
0.0
10.0
20.0
30.0
40.0
(n=11) (n=16)
a)
N
a
 (
m
g
/g
 d
ry
 w
g
t)
Female Male
0.0
5.0
10.0
15.0
(n=23) (n=24)
b)
K
 (
m
g
/g
 d
ry
 w
g
t)
Female Male
0.0
2.0
4.0
6.0
(n=23) (n=24)
c)
C
a
 (
m
g
/g
 d
ry
 w
g
t)
Female Male
0.0
0.2
0.4
0.6
(n=20) (n=20)
d)
 
Figure E.2 - Gender differences in Si (a), Na (b), K (c) and Ca (d) concentrations in VMS skin tissue 
samples. Data is shown as box-plots, where the horizontal lines indicate 10th, 25th, 50th (or median), 75th and 
90th percentiles; the open squares show the mean, n represents the number of subjects, female and male, 
considered in this study. Na, K and Si concentration were significantly higher in males compared with 
females (Na: P = 0.03, K: P = 0.0007 and Si: P = 0.02; Mann-Whitney t test). 
E.3.5 Contaminations & method validity 
 The TB samples were analysed and compare with the VMS samples to 
evaluate possible contaminations during the collection and to assess the validity of 
the analytical method. Comparison between TB and VMS data (Figure A.3) was 
only performed for samples from female donors, on account that TB samples were 
only collected from female donors and considering the gender differences 
observed with the VMS samples (Figure E.2). 
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Figure E.3 – Comparison of the VMS and TB samples for Si (a), Na (b), K (c) and Ca (d). TB and VMS 
elemental concentrations are presented for each female patient. Data is shown as box-plots, where the 
horizontal lines indicate 10th, 25th, 50th (or median), 75th and 90th percentiles; the open square shows the mean. 
In red are the VMS samples with suspected contamination. 
 The results represented in Figure A.3 mirrors the results previously reported 
of the mean differences between the TB and VMS samples (male plus female) 
(Table E.3), with marked differences in calcium and silicon concentrations with 
advancing age between the two groups/cohorts. Despite the differences in the 
absolute Si and Ca levels, the same trend with senescence is maintained between 
VMS and TB samples for these two elements. 
 The Si results from the contaminated VMS sample batch were clearly higher 
and with a wider concentration range when comparing to previous non-
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contaminated batches. Subsequently, the contamination source was identified as 
being the sponge antiseptic applicator used for the collection of that specific batch 
of samples.  
E.4 Discussion and Conclusion 
 The present pilot study investigated the effect of ageing and gender on Na, 
K, Ca and Si concentrations of the human skin. The results obtained suggested 
that males have generally higher skin Na, K and Si concentrations than females. 
This gender difference has also been previously reported in other human tissues 
for other trace elements8. 
 Skin silicon levels in female donors were found to increase significantly with 
ageing in the VMS cohort, and although the trend was reproduced in the TB 
cohort, the increase was less pronounced and not statistically significant. The 
reduced number of admissible samples in the VMS cohort was too small (n = 11); 
some samples were not considered because the Si levels were below the analytical 
quantification limit and others were excluded due to sample contamination. For 
these reasons this information has to be carefully considered and a greater number 
of subjects/samples should be analysed before asserting any definite conclusions 
made.  
 Calcium levels were also found to increase with ageing. Aging of the skin 
involves dermal changes and this is associated with damage to elastic and 
collagen fibres. No literature information is available but, much like other 
connective tissues, progressive increase in Ca tissue levels may be associated with 
advancing age and ECM degradation/calcification. 
 Essential elements such as Na, K and Ca reported a more constricted range 
and a limited distribution in concentration between subjects when compared to Si, 
which may in part result from homeostatic regulation mechanisms for these 
essential elements. Silicon is a ubiquitous element and may be affected by 
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environmental factors, such as cosmetics and dietary factors, so a wider scatter in 
Si concentrations observed both in TB and VMS samples was to be expected. 
Surprisingly, males presented a wider scatter than females in both skin groups. 
Considering the body area were the samples were collected (VMS: lower back and 
TB: breast area) it is unlikely that VMS samples, contrary to TB samples, were 
contaminated by residues from cosmetic usage. In fact, Si intake in males has been 
proved to be higher due to beer consumption, a highly bioavailable source of Si, 
which may account for the wider distribution in Si levels in the VMS skin samples 
from males9. 
 Trace-element determination, in most clinical specimens, represents a 
considerable challenge. Na and K occur in mg/g concentration in human skin. 
Therefore, with the adequate precautions against sample contamination during 
the collection and analysis, there are no other major analytical problems in the 
determination of these two elements. This is reflected by the similar results 
between the VMS and TB cohorts, which experience totally different collection 
procedures (VMS: punch skin biopsies and TB: breast surgery skin sample). 
Conversely, Ca and especially Si occur in lower levels in the human skin, being 
more susceptible to environmental sample contaminations. Although dramatic 
differences in absolute Ca and Si concentrations were observed between VMS and 
TB cohorts, the maintenance of the trend with ageing and the lower concentration 
range for these elements in the VMS cohort, suggests that the sample size 
difference between VMS (n = 47) and TB (n = 17) samples may be involved in the 
overall higher results for TB samples. Alternatively, and most likely, the difference 
in levels represent true differences in skin levels from two areas of the body: breast 
vs lower back. 
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 In conclusion, the results present in this Appendix may not provide absolute 
values on skin silicon and calcium levels, however an increase in silicon levels 
with age in females was noted. These preliminary results need to be followed up 
in more detail and the subject number increased, both for male and female donors. 
No age-related changes were observed in the sodium and potassium 
concentrations, but males have a higher content of these elements when compared 
to female donors. 
 It is also important to reiterate the importance of careful sample collection 
and handling to prevent environmental contaminations, especially in elements 
with low tissue concentrations, such as calcium and silicon. 
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